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Abstract & Key Words 
 
Active and passive pre-surgical orthopedic (PSO) devices are a controversial part 
of cleft palate management. There is no consensus as to the effects of these PSO 
devices on long-term outcomes and there is limited research comparing different 
PSO devices. The first objective of this research was to perform a systematic 
review of the literature surrounding the long-term effects of PSO device use. The 
second was to analyze and compare 10-year nasolabial aesthetic outcomes 
between patients treated with an active PSO device, passive PSO device, or no 
device. The final objective was to analyze and compare 10-year dental occlusion 
and facial growth in patients who received treatment with an active versus a 
passive PSO device. All patient data was assessed at 1, 5, and 10 years. 
Nasolabial aesthetics were assessed using patient photographs, dental occlusion 
was assessed using dental molds, and facial growth was assessed through 
cephalometric analysis. Systematic review identified 41 articles pertaining to long-
term effects of PSO device use. This systematic review didn’t identify a consensus 
as to the effects of these devices but did identify that all 41 articles had 
methodologic flaws that limit the applicability of their results. Comparison of 
nasolabial aesthetics showed that patients treated with a PSO device have 
comparable aesthetics at the 10-year mark to patients treated with no device who 
have less severe alveolar gaps. Patients treated with active and passive devices 
have similar dental occlusion/arch development and facial growth up to 10 years.  
 
Key words: cleft palate, cleft lip, pre-surgical device, pre-surgical orthopedics, 
latham device, nasoalveolar molding  
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Summary for Lay Audience 
 
Patients born with cleft lip and palate are often treated with a pre-surgical device 
prior to the surgical repair of their cleft lip. The role of this device is to help decrease 
the size of the gap in their palate, which in turn brings the edges of the lip closer 
together to facilitate the surgical repair of the lip. These devices can be active or 
passive. Active devices drive the edges of the cleft closer together with a pin and 
screw device, whereas passive devices gradually mold the cleft with a plate. The 
use of these devices is still controversial. The devices have been shown to improve 
patient outcomes but have also been shown to limit facial growth in these patients. 
In addition, there is very little research that has compared outcomes in patients 
depending on which type of device they received. The objectives of this study were 
to (1) review the research that has been done on these devices to see their long-
term effects on patient outcomes, and (2) look at the long-term effects of these 
devices on facial aesthetics, dental occlusion (how the teeth fit together), and facial 
growth in a group of patients that have received treatment with these devices. 
 
The literature review identified that research into the long-term effects of these 
devices is lacking. The research that does exist is limited by studies of poor quality. 
In addition, very few studies actually compared active and passive devices to see 
if one type of device is superior. Aesthetic outcomes for patients that received 
active or passive device treatment was similar between groups; aesthetics were 
comparable to patients with less severe clefts that did not require a device. Facial 
growth and dental occlusion were assessed at 5 and 10 years in patients with an 
active or a passive device. Dental occlusion and facial growth were both similar for 
patients treated with an active or a passive device up to 10 years of age.  
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Chapter 1: Introduction 
 
This chapter introduces the current state of knowledge regarding cleft lip and cleft 
palate. The embryology, important surgical anatomy, and classification of the cleft 
lip and palate are reviewed. Current standards of care for the management of cleft 
lip and palate are reviewed including cleft lip repair, cleft palate repair, and pre-
surgical orthopedic devices. Current methods of assessing outcomes in these 
patients including nasolabial aesthetic evaluation, dental arch/occlusion analysis, 
and cephalometric analysis are reviewed.  The objective, purpose, rationale, and 
hypothesis of this work are also given. 
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 EPIDEMIOLOGY OF CLEFT LIP AND PALATE 
 
Cleft lip and palate are common pediatric craniofacial malformations (1). In 
Canada, the incidence of cleft lip and palate in newborns is 0.82:1000 and the 
incidence of isolated cleft palate is 0.58:1000 (2). Cleft lip and palate can also be 
associated with various syndromes including Stickler syndrome (25% of cases), 
velocardiofacial syndrome (15%), and van der Woude’s syndrome (19%). 
Approximately 13.8% of cleft lip and palate, and 41.8% of isolated cleft palate, are 
associated with syndromes (3). A common triad of presentation in non-syndromic 
patients is the Pierre-Robin sequence which includes micrognathia/retrognathia, 
glossoptosis, and airway obstruction (3). The genetic association of non-syndromic 
cleft lip and palate is estimated at 20 to 50%, with environmental factors likely 
contributing to the remainder of cleft development (3). Environmental factors 
associated  with the development of cleft lip/palate include maternal smoking, 
maternal corticosteroid use, folic acid deficiency, high altitude, and increased 
parental age (3). 
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 EMBRYOLOGY OF CLEFT LIP AND PALATE 
 
The pathogenesis behind the development of cleft lip and palate is complex and 
multifactorial. The entire pathophysiology behind the process is not known, and 
many studies in this domain are animal studies (4). The following is an overview 
of the current state of knowledge of the pathophysiology behind the development 
of cleft lip and palate. 
 
Craniofacial tissues originate from neural crest cells and mesoderm. Neural crest 
cells migrate to the prominences of the face from the dorsal neural tube. During 
development in utero, the lip develops during the first 4 to 10 weeks of gestation 
and the palate develops between 4 to 12 weeks of gestation. The lip and palate 
are formed by the fusion of 7 facial prominences. Failure of the neural crest cells 
in these prominences to migrate to midline and fuse is what leads to cleft lip and 
palate deformities. Signaling molecules involved in the migration of neural crest 
cells to midline include Wnt, FOXE1, and IRF6 (3,4). 
 
The face is formed by 7 facial prominences (Figure 1): the frontonasal prominence, 
bilateral maxillary prominences, lateral nasal prominences, and the bilateral 
mandibular prominences. The frontonasal prominence gives rise to the forehead, 
central nose, philtrum, middle of the upper lip, and the primary palate. Interruption 
in the growth of the frontonasal prominence leads to bilateral cleft lip. The maxillary 
prominences give rise to the upper jaw, sides of the face, sides of the upper lip, 
and the secondary palate. Disruption of maxillary prominence growth can lead to 
clefts of the secondary palate and the lip. The lateral nasal prominences give rise 
to the nasal alae. Failure of fusion between the lateral nasal prominences and the 
frontonasal/maxillary processes can lead to clefts of the side of the nose. The 
mandibular prominences give rise to the lower jaw and lower lip. Disruption in 
growth of the mandibular prominences can result in mandibular clefts, although 
this is quite rare. Failure of fusion between the frontonasal and maxillary processes 
results in clefts of the primary palate (3,4).  
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Figure 1: Reproduced from Neligan et al. with permission from Elsevier publishing 
(4). Embryonic facial prominences and their corresponding adult facial structures. 
FNP= frontonasal prominence; MXP= maxillary prominence; LNP= lateral nasal 
prominence; MNP= mandibular prominence. 
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 CLEFT CLASSIFICATION  
 
There are several important definitions used when describing cleft lip and palate. 
Clefts can occur in the primary or the secondary palate. The primary palate 
extends from the base of the nasal processes to the incisive foramen of the 
alveolus. The secondary palate extends from the incisive foramen to the uvula. 
Clefts can be classified as unilateral or bilateral. Unilateral clefts are isolated to 
one side of the primary/secondary palate (either left or right) and bilateral clefts 
involve both sides. Clefts are also described as complete or incomplete. A 
complete cleft of the primary or secondary palate involves the entire unit of the 
palatal structure, whereas an incomplete cleft palate does not (4). See Figure 2  
for examples of cleft classification. 
 
 
Figure 2: Copyright Brito et al. (5), open access figure. Normal palate anatomy 
(upper middle image). (A) Unilateral complete cleft of primary palate, (B) Bilateral 
complete cleft of primary palate, (C) Unilateral complete cleft of primary and 
secondary palate, (D) Bilateral complete cleft of primary and secondary palate, (E) 
Complete cleft of secondary palate. 
 
 
 
 
6 
 
 
 SURGICAL ANATOMY OF THE CLEFT LIP  
 
The anatomy of the lip is important for understanding the principles behind surgical 
repair and assessing post-operative outcomes. The following is a brief overview of 
lip anatomy and changes in the anatomy associated with cleft lip. 
 
The lip itself is composed of several surface landmarks: philtral columns, philtral 
dimple, Cupid’s bow, vermillion border, and the vermillo-mucosal junction (Figure 
3). The philtral columns are created by the insertion of the orbicularis oris muscle 
fibers, and the philtral dimple is the concavity created by the paucity of muscle 
fibers between the two columns. The Cupid’s bow is the curve of the upper lip 
between the two philtral columns. The vermillion is the border between the red lip 
and the adjacent normal skin. The vermillo-mucosal junction is the border between 
the dry (keratinized) and the wet (non-keratinized) portions of the lip. Nose 
anatomy is also important when discussing clefts of the primary palate. Important 
structures of nasal anatomy include the alar base, the nasal tip, the nostrils, and 
the columella (Figure 3).  
 
There are 2 principle muscles that are relevant to the surgical repair of the cleft lip, 
the orbicularis oris and the levator labii superioris. The orbicularis oris muscle 
functions to move the lips for speech, facial expression, and eating. The levator 
labii superioris functions to elevate the upper lip. The lips receive their blood supply 
from bilateral superior labial arteries, their sensory innervation from the V2 of the 
trigeminal nerve, and motor innervation from the facial nerve (3).  
 
In patients with a cleft of the primary palate involving the lip, the orbicularis oris 
muscle inserts at the alar wing (at the edge of the cleft) instead of its usual insertion 
at the mucous membrane of the lip. There is also hypoplasia of the pars marginalis 
(a component of the orbicularis oris). A cleft of the primary palate involving the lip 
also causes shortening of the philtrum, diminished vermillion width on the non-cleft 
side, and increased vermillion width on the cleft side (3). A complete cleft of the 
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primary palate can cause multiple nasal deformities including nasal tip deviation, 
septal deviation (to the non-cleft side), widened and inferiorly positioned alar base 
(cleft side), collapsed lateral cartilage (cleft side), columellar shortening (cleft side), 
and inferior turbinate hypertrophy (cleft side) (3). 
 
 
 
Figure 3: Original photograph of important nasolabial landmarks. (1) Philtral 
column, (2) Philtral dimple, (3) Cupid's bow, (4) Vermillion, (5) Vermillo-mucosal 
junction, (6) Alar Base, (7) Columella, (8) Nostril, and (9) Nasal tip. 
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 SURGICAL REPAIR OF THE CLEFT LIP 
 
The objective of surgical repair of the cleft lip is anatomic re-creation of normal lip 
elements (Figure 3) and maintenance of the vertical height of the lip (6). When 
performing cleft lip repair the skin, muscle, and mucosal layers must be re-aligned 
(6). The most common repair techniques are the rotation advancement flap by 
Millard, triangular flap technique by Tennison, wave line closure by Pfeifer, and 
functional repair by Delaire. The techniques vary in their incision lines, but 
ultimately aim to restore anatomic alignment of the lip (7,8).  
 
In patients with a complete primary cleft palate, the alveolar gap makes lip repair 
difficult. Pre-surgical orthopedics (PSO) are frequently used in patients with large 
alveolar gaps prior to lip repair. The purpose of PSOs is to decrease the gap size, 
bring the lip elements closer together, re-establish the palatal arch, and aid with 
intra-oral feeding (9–11). Pre-surgical orthopedics include lip taping, lip adhesion, 
and PSO devices (11,12). On average, the surgical management of cleft lip is 
usually undertaken when the child is close to 3 months of age and PSOs are 
undertaken soon after birth and used until the time of lip repair (6). 
 
At the time of lip repair, a gingivoperiosteoplasty (GPP) can also be performed to 
close the alveolar gap. The purpose of a GPP is to close the alveolar gap, reduce 
the necessity for bone grafting, and recreate an anatomic palatal arch (13,14).  
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 SURGICAL ANATOMY OF THE CLEFT PALATE 
 
The anatomy of the palate is important for understanding how cleft palate is 
managed and for assessing post-operative outcomes. The following is a brief 
overview of palate anatomy and changes in the anatomy associated with cleft 
palate. 
 
The palate is composed of the hard and the soft palate (Figure 2). The hard palate 
is the boney structure that functions as a rigid floor for the nasal cavity. The hard 
palate is composed of the premaxillary portion, the palatine processes of the 
maxilla, and the palatine processes of the palatine bone. The hard palate receives 
its blood supply from the greater palatine, nasopalatine, anterior superior alveolar, 
and posterior superior alveolar arteries. The hard palate receives its innervation 
from the greater palatine and nasopalatine nerves. The soft palate is the 
fibromuscular structure posterior to the hard palate that moves to open and close 
the Eustachian canals.  The muscles that form the soft palate include the levator 
veli palatini, tensor veli palatini (TVP), palatopharyngeus, palatoglossus, the 
musculus uvulae, superior pharyngeal constrictor, salpingopharyngeus, and the 
stylopharyngeus. Blood supply to the soft palate originates from the ascending 
pharyngeal and ascending palatine arteries. Innervation is supplied by the cranial 
nerve 5 (TVP only) and pharyngeal plexus (remaining muscles) (3).  
 
The palate can further be divided into the primary palate and secondary palate. 
The primary palate lies anterior to the incisive foramen and includes the lip, nostril 
sill, alveolus, and the portion of the hard palate that is anterior to the incisive 
foramen. The secondary palate lies posterior to the primary palate and includes 
the hard palate posterior to the incisive foramen and the soft palate  (3).  
 
Changes to palate anatomy vary depending on the extent of the cleft. Typically, 
muscle fibers of the involved muscles are hypoplastic and more connective tissue 
lies within the muscular bed (3).  
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 SURGICAL REPAIR OF CLEFT PALATE 
 
The objective of surgical repair of the cleft palate is to allow for good speech 
development, velopharyngeal function, and midface development. Three layers 
must be addressed in palate repair: the nasal layer, the muscle layer, and the oral 
mucosa layer. Techniques for palate repair include the von Langenbeck 
palatoplasty, Veau-Wardill-Kilner palatoplasty, Furlow double opposing Z-
palatoplasty, vomer flaps, and the intra-velar veloplasty (7,8).  
 
Repair of the palate can either be done in 1 stage or 2 stages; 2-stage repair 
involves fixing the hard and soft palate at 2 separate times. Two stage repair is 
beneficial for midface growth, but does have a detrimental effect on speech 
development in addition to the need for an additional operative procedure and 
anesthesia (7). It is still unclear from the literature which technique/method results 
in the best speech outcomes with the least effect on growth (15–20). 
 
 
 TIMING OF SURGERY 
 
Timing of surgery for cleft lip and palate is crucial for proper growth and speech 
development and is still highly debated among cleft palate surgeons. It has been 
shown in the literature that patients with untreated cleft lip and palate have normal 
growth of the nasomaxillary complex (21,22), whereas patients who have had lip 
and palate repairs have diminished growth (23). Ultimately, this indicates that 
surgical management may cause limitations in growth. This presents cleft 
surgeons with the challenge of balancing the timing of cleft palate repair for 
appropriate speech development, while limiting the negative impact on growth.  
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Advocates for early surgical management believe that surgical closure of the 
palate allows for improved speech development, while advocates of late palate 
closure believe that the closure itself causes a growth deficit (24–26). Previous 
research from the Oxford Cleft Palate Study Team shows greater speech 
deficiencies (articulation, nasal resonance, intelligibility and substitution pattern) in 
patients with delayed hard palate closure (4 years) compared to those with early 
palate closure (1 year) (27). No difference in maxillofacial growth was found 
between the groups. Conversely, Bardach et al. found improved facial growth in 
patients with delayed hard palate closure (up to 12-15 years), but higher incidence 
of velopharyngeal insufficiency (25). Rohrich et al. studied outcomes in patients 
with early versus delayed closure and found that delayed closure resulted in 
significant speech impairments with little difference in overall maxillary growth (27). 
Shaffer et al. also found higher rates of language delay and need for speech 
therapy in patients with delayed palate repair (over 13 months) (28). Evidence from 
the Scandcleft studies have demonstrated no significant difference in dental arch 
or maxillary development in patients who had palatal surgery at 12 versus 36 
months (29,30).  
 
Overall, the timing for palate surgery is still highly debated. The trend with cleft 
palate surgeons in North America is to perform a single stage cleft palate surgery 
at 9 to 12 months of age for improved patient speech outcomes and reduced risk 
of maxillary growth disturbance (31–34).  
 
 
 
  
 
 
 
12 
 
 
 MANAGEMENT OF CLEFT LIP AND PALATE AT OUR INSTITUTION 
 
At our institution the management of patients with cleft lip and palate is a multi-
staged, multi-disciplinary approach involving plastic surgery, otolaryngology, 
speech and language therapy, social work, and dentistry (34). The primary goal of 
cleft palate surgery is to achieve satisfactory functional (e.g. eating, speech) and 
aesthetic results (1). 
 
At our institution, cleft lip repair is usually performed at 3 months of age and cleft 
palate repair is performed at 12 months. All patients with a cleft lip receive a 
modified Mohler lip repair. Patients with a cleft of the secondary palate receive a 
Furlow palatoplasty, hybrid palatoplasty, or von Langenbeck palatoplasty 
depending on whether the cleft is complete or incomplete. Pre-surgical orthopedic 
devices are often used to narrow the alveolar gap and facilitate intra-oral feeding 
prior to cleft lip repair. At our institution, the decision to use a PSO device is made 
at the first clinic visit which is usually 1 to 2 weeks post-birth. Families with a patient 
that has an alveolar gap greater than 4mm are offered pre-surgical management 
with a PSO device. If the patient is to receive a PSO device, they are sent to an 
orthodontic specialist where a plaster cast of their cleft is made. This cast is used 
to design either an active or a passive molding device. Passive molding devices 
can be inserted in the office, but active PSO devices require insertion in the 
operating room under general anesthesia. Active devices require parents to turn a 
screw on the device daily to re-approximate the edges of the cleft. For a passive 
device, the patient and caregiver are expected to come for regular follow-ups visits 
to gradually mold the device. The decision of which PSO device to use is made 
based on the severity of the alveolar gap, the caregiver’s capacity to handle care 
of the device at home, and caregiver preference.  Figure 4 gives a visual 
representation of the management protocol that a patient with cleft lip and palate 
receives at our institution. 
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Figure 4: Overview of management process for CL/P and CP patients at our 
institution. ENT= otolaryngology, SLP= speech language pathology. 
 
  
 
 
 
14 
 
 
 
 PRE-SURGICAL ORTHOPEDIC DEVICES 
 
1.10.1 Active Devices  
 
Active PSO devices are designed to drive the edges of the alveolar gap closer 
together using pins or screws (35). One of the most commonly used active devices 
is the Latham appliance. It was first introduced by Latham and Millard in 1990 (36).  
The Latham appliance (Figure 5) is a pin-retained intra-oral device that utilizes a 
mechanical screw that is turned daily by the parents to approximate the edges of 
the alveolar gap by approximately 0.5mm per day (37–39).  
 
Active devices were initially designed to be used in conjunction with GPP to narrow 
the alveolar gap prior to lip repair to facilitate the repair and prevent dehiscence 
(40,41). Multiple studies have shown that active devices and GPP improved 
aesthetic outcomes, allowed for adequate maxillary growth, and decreased the 
number of nasoalveolar fistulas (37,41,42). Unfortunately, active devices  in 
conjunction with GPP have also been identified to cause decreased maxillary 
protrusion and height throughout development, reduce successfulness of 
secondary bone grafting, and have no effect on the number of patients that require 
secondary bone grafting (43,44). Following these more recent studies, the use of 
GPP in patients has decreased significantly.  
 
The effect of the active device alone is still debated. Lin et al. have found that the 
active device is associated with an increased incidence of ectopic permanent 
maxillary first molars compared to patients without a device (45). Chan et al. have 
shown that compared to patients treated with no device, there is no difference in 
long-term (10-year) dental occlusion or growth in children treated with an active 
device (46). Kornbluth et al. have also shown that active devices are associated 
with improved nasolabial aesthetic outcomes, but cause a midface growth 
disturbance (35). Overall, there is still no conclusion about the effects of the active 
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device and high level evidence is lacking (35). Further research must be done to 
establish the effect of the active device without GPP on growth outcomes in 
patients with cleft lip and palate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 5: The Latham device is pictured above on a patient mold (left) and in-situ (right). 
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1.10.2 Passive Devices  
 
Passive PSO devices have the same overall objective as active PSO devices, but 
do not actively drive together the edges of the alveolar gap. Instead, passive 
devices are intra-oral plates that are custom fit to patients. These devices are 
modified weekly to help bring the oronasal structures into a more anatomic 
position. Ideally, passive molding is started in the first week of life and used in 
patients with a cleft of 3 to 8mm (47). Passive PSO devices work because of the 
plasticity of neonate cartilaginous and boney structures shortly after birth (47,48). 
An example of a passive PSO device is the nasoalveolar molding (NAM) device 
(Figure 6). NAM was first described in 1993 by Barry Grayson and works by 
molding the alveolar segments and nose through a custom-fit intra-oral appliance 
with nasal stents. 
 
Multiple studies have shown that when compared to the contralateral non-clefted 
side, passive devices appear to improve several aesthetic factors including 
columella length, columella deviation, nostril width, and nasal height (48–50). 
Passive devices have also been shown to improve nasolabial aesthetic outcomes 
when compared to patients treated without a PSO device (51,52). In regards to the 
effect of these devices on growth, it has been shown that they decrease the size 
of the alveolar gap in the short term (less than 2 years of age) (53,54). Previous 
studies have compared patients who received a passive device to those who did 
not, and passive molding has been shown to improve dental arch symmetry and 
maxillary growth until 6 years of age (54).  
 
Contrasting evidence has also been published on passive molding. Prahl et al. as 
part of the Dutchcleft study group showed that passive PSO devices do not 
improve contact between the alveolar segments of the cleft or prevent long-term 
(6-year) alveolar collapse (55,56). Similar results have been found by other groups 
(57,58). Studies have also proposed that passive molding provides no 
improvement in nasolabial aesthetics compared to patients who received no 
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device (59).  With respect to the effect on dental development and facial growth, 
several studies have shown no long-term effects of passive molding on maxillary 
growth and dental arch relationships when compared to patients treated with no 
device (46,55,56), 
 
Overall, the benefits of passive PSO devices are still debated. One of the most 
strongly supported benefits is that passive devices can help improve nasal 
aesthetics and narrow the cleft (48,49). There is limited research that actually 
examines the long-term benefits of passive molding (54,60).  
 
 
 
Figure 6: Original photograph. A custom-made NAM device is pictured above. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
18 
 
 
1.10.3 Comparing Active and Passive Devices 
 
In the field of cleft palate research there are very few studies comparing active 
versus passive molding devices. The trend in cleft palate management is to either 
use active molding or passive molding, and there is very limited data that actually 
compares the two methods of molding. Kornbluth et al. have compared patient 
outcomes that were treated with active or passive devices compared to those 
treated without a device (35). Unfortunately, this study did not report statistics for 
the comparison between the active and passive device groups specifically, 
although they appeared to have similar results between the two groups for 
nasolabial aesthetics, facial growth, and dental occlusion. A major limitation in this 
study was that patients in the different device groups were treated by different 
surgeons using different management protocols. It is difficult to compare outcomes 
in patients treated with active versus passive devices when these confounding 
variables could influence results. A comparison of active and passive molding 
techniques where confounding variables are eliminated would be beneficial for 
determining if certain techniques are superior for patient outcomes including 
midface growth, dental occlusion, and nasolabial aesthetics (35).  
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 METHODS OF ASSESSING POST-OPERATIVE AESTHETIC OUTCOMES 
 
1.11.1 Nasolabial Aesthetics  
 
Patients with cleft lip and palate undergo multiple surgical interventions in order to 
ensure adequate functional and anatomic correction of the cleft deformity (61). 
Despite these corrections, patients have been found to have persistent anatomic 
deformities including abnormal nasal shape, scarring of the upper lip, and uneven 
vermillion border (62,63). While certain studies have reported no psychosocial 
concerns for patients with cleft lip and palate compared to patients without, several 
systematic reviews have shown that patients with cleft lip/palate are at higher risk 
for dissatisfaction with facial appearance, behavioural problems, and impairment 
in social functioning (64,65). Therefore, it is important to use an objective 
assessment tool for evaluating nasolabial aesthetic outcomes to ensure 
satisfactory aesthetic results. 
 
Aesthetic scales are frequently used in plastic surgery to assess post-operative 
outcomes and the same tools are used for assessing outcomes in patients with 
cleft lip/palate. Scales used to assess nasolabial aesthetics can be divided into 
quantitative and qualitative scales. Quantitative scales use specific anthropometric 
measurements to evaluate different soft tissue landmarks on patient photographs 
for overall symmetry (66,67). Qualitative scales are used to evaluate aesthetics on 
patient photographs and include ordinal scales, visual analog scales, and ranking 
scales (62). Previous research shows that ranking scales have the greatest intra-
rater reliability, followed by visual analog scales and ordinal scales (63).  
Historically, 2-dimensional (2-D) photographs have been used to assess post-
operative outcomes, but studies have begun using 3-dimensional (3-D) images as 
well. When comparing 2-D and 3-D images, 3-D images have greater intra-rater 
reliability but scoring of patients evaluated with the two modalities is not different 
(68). 
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The focus of nasolabial aesthetic assessment in patients with cleft lip and palate 
is often on nasal form, nasal symmetry, vermillion border form, and lip symmetry. 
These aspects of the nose and lip are disrupted in cleft lip/palate and repair is 
meant to bring the nose and lip back into an anatomic position (61,69). Important 
components of nasolabial aesthetic outcomes include the scar, alar base 
symmetry, columellar deviation, nasal tip recurvatum, nostril symmetry, Cupid’s 
Bow symmetry, the vermillo-cutaneous junction, and the vermillo-mucosal junction 
(Figure 7) (61,69). 
 
  
 
Figure 7: Original photographs. Important landmarks to assess nasolabial aestehtics include (A) 
symmetry of Cupid’s Bow and the vermillo-cutaneous junction, (B) symmetry of the vermillo-
mucosal junction, (C) alar base symmetry, (D) scar quality and position, (E) nostril symmetry, and 
(F) nasal tip symmetry. 
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 METHODS OF ASSESSING POST-OPERATIVE GROWTH OUTCOMES 
 
1.12.1 Angle Classification  
 
Dental occlusion is defined as the way in which the maxillary and mandibular teeth 
fit together. Classically, occlusion is described using the Angle classification. The 
Angle classification is the gold standard for describing occlusion and was initially 
developed in the 1890’s to describe dental occlusion based on the position of the 
mesiobuccal cusp of the maxillary first molar to the  buccal groove of the 
mandibular first molar (70). The Angle classification system is as follows (Figure 
8): (1) Normal occlusion, (2) Class I having normal molar relationship despite tooth 
rotation or crowding, (3) Class II having lower molars distal to upper molars, and 
(4) Class III having lower molars mesial to upper molars (71).  
 
The Angle classification system is widely used for classifying occlusion but has 
been criticized for being a 2-D classification of a 3-D problem. The Angle 
classification is useful for characterizing sagittal occlusion, but other scoring 
systems have been described for assessing occlusion in a 3-D way.  
 
 
  
Figure 8: Original images. Angle classification system of occlusion. 
1.12.1.1.1 GOSLON Yardstick  
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Several different methods for scoring dental arch relationships have been used in 
the CL/P population. The GOSLON Yardstick is the gold standard for measuring 
skeletal and dental relationships in patients with CL/P and was first developed in 
1987 (35,72). The GOSLON Yardstick classification rates the occlusion into 1 of 5 
categories using the anteroposterior, vertical, and sagittal dimensions of 3-D casts 
of patients’ mouths.  This classification system provides a general prediction about 
future requirements for surgery  (73). The GOSLON Yardstick is based on the 
distance between the incisal edge of the maxillary incisors and the labial surfaces 
of the mandibular incisors, termed “overjet”. The five grades are as follow: 
 
Group 1 Positive overjet  Minimal or no treatment required 
Group 2 Positive overjet  Minimal treatment required 
Group 3 Edge to edge bite Orthodontic treatment required, but good 
outcome anticipated 
Group 4 Negative overjet  
(1-3mm) 
Orthodontic treatment required with 
possible future orthognathic surgery 
Group 5 Negative overjet (>3mm) Definite orthognathic surgery required 
 
The GOSLON yardstick is a useful tool for analyzing occlusion and predicting the 
need for future orthognathic intervention (74). See Figure 9 for photographs of 
patient molds with different grades of occlusion.  
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A 
B  
C  
Figure 9: Original photographs. Patient molds representing: (A) Positive 
overjet, GOSLON Yardstick Grade 1/2; (B) No overjet, GOSLON Yardstick 
Grade 3; (C) Negative overjet, GOSLON Yardstick Grade 4/5. 
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1.12.2 Modified Huddart/Bodenham Classification 
 
The Modified Huddart/Bodenham (MHB) classification is another classification 
system of dental occlusion that was initially developed in 1997 for primary dentition 
and modified in 2003 to apply to mixed/permanent dentition (75). The MHB system 
classifies the position of each maxillary tooth in relation to its mandibular tooth 
partner. Each relationship is given a score from -3 to +1 and the mean score for 
each relationship is calculated (Figure 10); a more negative score indicates worse 
dental relationships. In primary dentition, the two central incisors, bilateral canines 
and bilateral molars are measured to total 8 categories of evaluation. In primary 
dentition the total MHB score can range from -24 to +8. In mixed/permanent 
dentition the two central incisors, bilateral canines, bilateral pre-molars, and 
bilateral first permanent molars are measured to total 10 categories of evaluation. 
In mixed/permanent dentition the total MHB score can range from -30 to +10 (75).  
 
In regard to whether the GOSLON yardstick or the MHB classification is superior 
for classifying occlusion, this is still highly debated. In the literature, both have been 
favored for different reasons. The MHB system is less subjective than the 
GOSLON Yardstick and appears to be more versatile for primary versus 
permanent dentition (30,76). The GOSLON Yardstick is more user-friendly and 
has been used for much longer than the  MHB (76). Ultimately, controversy still 
remains about which classification system is best. Comparative studies have 
shown that MHB has been found to be superior for 5-year (primary) dentition, but 
GOSLON Yardstick is preferred for 10-year (permanent) models (72,76).  
 
 
 
25 
 
 
 
Figure 10: Reproduced with permission from Sage Publishing. Modified Huddart 
Bodenham classification of molars, canines, and incisors. 
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1.12.3 Dental/Occlusal Changes in Cleft Lip & Palate 
 
Cleft lip and palate can produce a variety of dental problems including 
missing/additional teeth and abnormal shape and position of both deciduous and 
permanent teeth. Most commonly, teeth in the area of the cleft are affected. The 
most common orthodontic problem in patients with CL/P is maxillary asymmetry 
causing crossbite formation (7). The overall effect of cleft size on dental occlusion 
is still debated. Some authors have found that there is no relationship between the 
size of the cleft and occlusion (77,78). Conversely, several studies have shown 
that initial cleft size negatively affects maxillary inclination, which in turn affects 
occlusion (74,79). The effect of cleft size on dental arch and occlusal relationships 
is more likely to be multifactorial, with type and timing of palate repair also affecting 
the outcome (74).  
 
 
1.12.4 Palatal Measurements 
 
The width of the anterior and posterior palate represents the overall width of the 
palate and is important for understanding the space that the dental arch has for 
the teeth. The inter-canine width (ICW) and sum of the incisors (SI) represent the 
width of the anterior dental arch, and the inter-palatal molar width (IPMW) 
represents the width of the posterior dental arch (80). Inter-canine width is the 
distance between the maxillary canine grooves and IPMW is the distance between 
the retromolar points of the maxillary permanent first molars or deciduous second 
molars. The sum of the incisors is the maximum mesiodistal size of each of the 
four incisors (81). Reduction in maxillary dental arch width is a common concern 
with cleft palate and measuring arch width can help monitor growth and 
development of the dental arch. See Figure 11 for important dental arch 
measurements.   
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Figure 11: SI= sum of incisors, ICW= inter-canine width, IPMW= inter-palatal molar 
width 
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1.12.5 Cephalometric Analysis 
 
Cephalometric measurements represent the gold standard for measuring facial 
growth and development (35). Cephalometric landmarks are plotted on lateral 
facial radiographs and used to analyse hard tissue points of interest that affect 
facial features. Historically, radiographs have been traced by hand to plot 
landmarks. More recently, programs such as Dolphin Imaging™ have been 
designed to plot landmarks and calculate measurements electronically (82).  
 
There are two main functions of cephalometric analysis: (1) to compare facial 
morphology against a matched norm and (2) to assess facial growth in a patient 
(82). Cephalometric measurements can help monitor stability of the facial skeleton 
and determine whether surgical intervention is required to help correct deformity.  
 
Traditionally, hard tissue markers have been used for cephalometric analysis. 
Boney landmarks do not predict soft tissue changes, so soft tissue traits must also 
be taken into consideration when analyzing facial morphology (83). Cephalometric 
analysis has now been modified to include soft tissue points of interest to help 
better analyze facial growth outcomes. Important boney cephalometric landmarks 
include sella turcica (S), nasion (N), A-point (A), posterior nasal spine (PNS), 
anterior nasal spine (ANS), basion (Ba), B-point (B), pogonion (Pg), and menton 
(Me) (Figure 12) (44,82–84). Important soft tissue landmarks include glabella (G’), 
pronasale (Pn’), soft tissue pogonion (Pg’), columella (Col), subnasale (Sn), upper 
lip (UL), soft tissue A-point (A’), soft tissue nasion (N’), and soft tissue B-point (B’) 
(Figure 13) (44,82–84).  
14 
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Figure 12: Original photograph. Cephalometric tracing of lateral patient x-ray. 
Important boney landmarks identified (in blue). (1) Sella Turcica, (2) Nasio, (3) A-
point, (4, 5) Posterior and Anterior Nasal Spine, (6) Basion, (7) B-point, (8) 
Pogonion, (9) Menton. 
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Figure 13: Original photograph. Cephalometric tracing of lateral patient x-ray. 
Important soft tissue landmarks identified (in blue). (1) Glabella, (2) Nasion, (3) 
Pronasale, (4) Columella, (5) Subnasale, (6) A-point, (7) Upper lip, (8) B-point, (9) 
Pogonion. 
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1.12.6 Brief Overview of Important Facial Relationships 
 
There are five functional components of a cephalogram: cranial base/cranium, 
skeletal maxilla, skeletal mandible, maxillary dentition, and mandibular dentition. 
There are two ways of standardizing cephalograms with a horizontal reference 
plane: the Frankfort plane or the natural head position. The Frankfort plane creates 
a horizontal reference plane between the external auditory meatus to the anterior 
inferior orbital rim. The natural head position parallels the patient’s visual axis by 
having the patient look at an object at the distant horizon (85).  
 
Cephalometric analysis is important for analysis of growth, but these boney 
relationships can also help describe occlusion and predict facial attractiveness in 
patients. In addition, there exist some soft tissue relationships that are also 
predictive of facial attractiveness (85). These relationships can be quantified using 
cephalometric analysis. Cephalometric landmarks act as the foundation to create 
different cephalometric measurements that reflect important areas of facial growth 
and development. See Table 1 for a list of common cephalometric measurements 
and their importance for analyzing growth.  
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 Landmarks Definition 
M
a
x
ill
a
 
SNA Position of maxilla relative to anterior cranial base 
N-A Horizontal distance between nasion and A-point 
PNS-ANS Maxillary length 
Ba-A Depth of midface 
Ba-ANS Length of maxilla 
Ba-N-ANS Maxillary position at ANS 
Ba-N-A Maxillary position at A-point 
M
a
n
d
ib
le
  
SNB Position of mandible relative to anterior cranial base 
N-B Horizontal distance between nasion and B-point 
N-Pg Horizontal distance between nasion and pogonion 
Ba-N-Pg Mandibular position at pogonion 
Ba-N-B Mandibular position at B-point 
D
e
n
to
-
a
lv
e
o
la
r 
 ANB Relative position of maxilla to mandible 
ANS-N-A Alveolus to basal bone measurement 
ANS-N-Pg Basal bone difference 
V
e
rt
ic
a
l 
F
a
c
e
 N-ANS Upper facial height 
ANS-Me Lower facial height 
N-ANS/ANS-Me Upper to lower face ratio 
N-ANS/N-Me Midface percentage of total facial height 
S
o
ft
 
T
is
s
u
e
  N’-A’-Pg’ Soft tissue convexity 
Gn’-Sn-Pg’ Facial contour angle 
Col-Sn-UL Nasolabial angle 
Table 1: Important cephalometric measurements and the growth parameters that 
they represent (56). 
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Figure 14: Maxillary cephalometric measurements. 
 
 
Figure 15: Mandibular cephalometric measurements. 
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Figure 16: Dento-alveolar cephalometric measurements. 
 
 
Figure 17: Vertical facial growth cephalometric measurements. 
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Figure 18: Soft tissue cephalometric measurements. 
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1.12.7  Facial Growth in Cleft Lip & Palate 
 
Differences in facial morphology in patients with cleft lip and palate compared to 
patients without a cleft include (1) shortened maxilla and mandible, (2) reduced 
posterior maxilla height and increased width, (3) reduced palate size, oropharynx 
and pharyngeal depth, (4) reduced posterior mandible height, (5) bimaxillary 
retrognathia, (6) inferior position of hyoid, (7) reduced tongue height and velar 
length, (8) reduced nasolabial angle, (9) reduced percent nose, and (10) reduced 
mandibular incisor projection and inclination (84,86–89). There does not appear to 
be any difference in skull base anatomy between patients with and without cleft 
palate (90,91).  
 
Patients with larger alveolar gaps have been shown to have poorer maxillary 
protrusion and length (84,92). It has previously been shown in patients with cleft 
lip and palate that overall midface growth in patients that do not undergo lip or 
palate repair is similar to patients without any cleft. This finding has led to the 
conclusion that surgical intervention does cause a growth disturbance (7). Liao et 
al. have shown that when compared to patients who received lip repair only, palate 
repair leads to limited anteroposterior development of the maxilla, and decreased 
forward displacement (93).  Several other studies have shown similar outcomes in 
regards to the effect of palate repair on maxillary growth (21,23). Several studies 
have shown that pressure from the lip repair can cause the upper anterior teeth to 
become retroclined, leading to an anterior crossbite (7,94–97).  
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 THESIS RATIONALE  
 
The use of PSO devices in the management of patients with CL/P remains 
controversial. In addition, few research studies actually compare patient outcomes 
achieved by different types of PSO devices (35).  To date, limited research has 
compared long-term facial growth, dental occlusion, and nasolabial aesthetics 
between patients who received an active PSO device versus a passive PSO 
device. The research that does exist on this topic is limited by small patient cohorts 
with multiple surgeons and management protocols within the same experimental 
group (35,98). At our institution we have a single surgeon that has been using 
active and passive PSO devices for over 15 years. All of these patients receive the 
same operative and non-operative cleft management, except for the PSO device 
used. This presents us with the unique opportunity to examine outcomes in a single 
surgeon’s cohort of patients over a long-term period.  By using a cohort of patients 
operated on by a single surgeon with the same management protocol we can 
eliminate some of the unnecessary confounding variables which are present in the 
majority of current cleft palate literature (35,98).  
 
Both active and passive PSO devices have their strengths and weaknesses. 
Passive devices have an increased burden of care on the patient’s families 
because they require weekly device adjustments. Active PSO devices require 
fewer follow-up visits, but have the added risk and cost associated with operative 
insertion of the device.  With steps towards reducing unnecessary procedures, 
risks, and costs in the medical system, it is important to determine whether one 
type of PSO device produces superior results. The results from this thesis will be 
important for determining management of patients with CL/P moving forward. 
Overall, this work will give a more conclusive answer about the effects of the PSO 
devices on nasolabial aesthetics, dental occlusion, and facial growth. In addition, 
this will be the first study of its nature to compare outcomes in patients that 
received an active versus a passive device.   
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 RESEARCH OBJECTIVES AND HYPOTHESIS 
 
There are 4 principle objectives to this research:  
 
1) Perform a systematic review of current literature describing the long-term 
effects of different PSO devices used for the management of cleft palate.  
2) Evaluate and compare the nasolabial aesthetic changes in patients who 
were treated with an active PSO device, passive PSO device, or no PSO 
device at 1 year, 5 years, and 10 years. 
3) Evaluate and compare dentoalveolar development/occlusion in patients 
who were treated with an active or passive PSO device at 5 years and 10 
years. 
4) Evaluate and compare the facial growth in patients who were treated with 
an active or passive PSO device at 5 years and 10 years. 
 
We hypothesize that nasolabial aesthetics, dentoalveolar development, and facial 
growth will be comparable between patients that received active PSO devices and 
passive PSO devices. We hypothesize that active and passive PSO devices will 
make nasolabial aesthetics in patients with larger alveolar gaps comparable to 
patients who had smaller gaps and did not require a PSO.  
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Chapter 2: Systematic Review of the Literature on the Long-term Patient 
Outcomes Associated with Pre-Surgical Orthopedic Devices 
 
The use of pre-surgical orthopedic devices in cleft lip/palate patients is 
controversial. The literature that exists on this topic is extremely varied. The 
purpose of this chapter is to outline the current state of knowledge of the long-term 
outcomes of patients with cleft lip/palate treated with pre-surgical devices prior to 
lip repair. 
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 INTRODUCTION 
 
Clinical use of active and passive presurgical orthopedic (PSO) devices for the 
management of patients with cleft lip/palate is a controversial topic. It is widely 
accepted that these devices are useful for decreasing alveolar gap size prior to lip 
repair (99–102), but their long-term effects on nasolabial aesthetics,  dental 
occlusion, and facial growth are still debated (35,54,103–108). Consequently, the 
use of these devices is dependent on surgeon experience and caregiver 
preference (30).  
 
To date, there is a large body of research examining the outcomes of patients 
treated with PSO devices, but there is no consensus on their effect on long-term 
patient outcomes (35,98). The lack of consensus on the use of these devices is 
likely in part due to the quality of the research itself. Research in cleft lip and palate 
is often limited by small sample sizes and variable management protocols. 
Frequently, patients from numerous sites and surgeons are included in a single 
study to try and increase the study cohort. While advantageous for increasing the 
power of studies, grouping patients undergoing dissimilar management ultimately 
creates confounding factors within the studies (e.g. surgeon experience, surgical 
procedure) (35,102,109).  The variability that exists within and in between 
comparison groups creates bias and confusion when drawing conclusions from the 
research performed. In addition, there is also a paucity of research actually 
comparing the difference in outcomes between patients treated with different types 
of PSO devices (35). 
 
The primary purpose of the research in this chapter was to complete a systematic 
review of the literature pertaining to the use of PSO devices in cleft lip/palate and 
their effect on long-term patient outcomes.  
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 METHODOLOGY 
 
A comprehensive literature review of Embase and Ovid databases was performed 
to identify all English-language publications related to unilateral cleft palate, 
presurgical devices, and patient outcomes. Selection criteria for included studies 
were as follows: 
 
Inclusion criteria: 
• Describe the use of PSO for unilateral cleft palate management 
• Describe patient outcomes past removal of device 
• Include human subjects  
• English-language articles 
• Published at any date  
• Any study design, including case series (>10 cases)  
 
Exclusion criteria: 
• Do not describe the use of PSO for cleft management 
• Do not describe patient outcomes past removal of device 
• Control group is patients without a cleft lip/palate 
• Did not separate unilateral and bilateral cleft outcomes 
• Study designed to validate a small modification of a previously validated 
device  
• Case report (<10 cases) 
• Non-original studies 
 
Key search terms included: “cleft lip”, “cleft palate”, “preoperative care”, 
“orthodontics”, “palatal obturators”, and “infant”. An academic librarian was 
involved to help build the literature search. All of the abstracts were reviewed 
independently by two reviewers. Any disagreement about the inclusion of a study 
was resolved by consensus. In addition, the reference lists of the included articles 
were hand-searched for any articles missing from the database search. Following 
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the full-article review, a total of 41 articles were included in this systematic review. 
Figure 19 describes the process of inclusion and exclusion of articles in this study.  
 
The following data was collected for each paper: (1) study title, (2) authors, (3) 
year of publication, (4) journal of publication, (5) type of publication, (6) number of 
patients included in study, (7) type of PSO device used, (8) whether patient 
management protocols were standardized within and between groups, (9) 
outcomes measured, (10) age of patients at analysis, and (11) conclusions drawn 
about the device being evaluated. Meta-analysis was not performed due to the 
heterogeneity of reported results. 
 
 
 
 
Figure 19: Flowchart of study inclusion. 
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 RESULTS 
 
The literature search yielded a total of 438 studies to review, of which 41 studies 
met criteria for inclusion in the systematic review (35,45,46,51,54–
58,101,103,107,108,110–136). Of the 41 studies, 30 were retrospective studies 
and 11 were prospective studies. See Table 2 for the list of all included articles, 
year of publication, and type of study.  
 
On average, studies had a total of 32.9 patients per intervention group. Sixteen 
articles examined outcomes in patients under 5 years of age, 25 articles for 
patients 5 to 10 years old, and 4 articles for patients over 10 years old. Of the 41 
research articles, 23 focused on passive devices, 8 on active devices, and 10 
compared active and passive devices. In total, 13 articles described nasolabial 
aesthetics, 9 described facial growth, 23 described dental arch/occlusion 
outcomes, 1 described rates of revision surgeries, and 1 described changes in 
airway anatomy. For articles reporting on dental arch outcomes, 22% reported that 
the PSO device improved dental arch/occlusion, 22% reported that the PSO device 
caused worse dental arch/occlusion, and 56% reported no difference in outcomes 
between patients that had a PSO device compared to those that did not (Figure 
20). For articles reporting on nasolabial aesthetic outcomes, 64% reported 
improvement in nasolabial aesthetics with the use of a PSO device and 36% 
reported no difference in outcomes between patients that did have a PSO device 
compared to those that did not (Figure 20). For articles reporting on facial growth 
outcomes, 33% of studies reported that PSO devices worsened facial growth and 
67% reported no difference in outcomes between patients that did have a PSO 
device compared to those that did not (Figure 20). The sole article reporting on 
airway measurements described no difference in outcomes between patients that 
did have a PSO device compared to those that did not. The sole article reporting 
on rates of revision surgery described a reduced number of revision surgeries in 
patients that had a PSO device (Figure 20). 
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A total of 11 articles examined a patient cohort from a single surgeon’s practice, 
21 used a cohort from multiple sites and/or surgeons, and 9 examined a cohort 
from one site with an unspecified number of surgeons involved in the care of the 
patients. Consistency in management protocols was quite variable between these 
3 groups (Figure 21). Variability in the protocols included different operating 
surgeons (73%), different type and timing of lip and/or palate repair (41%), whether 
or not patients received GPP (10%), and whether patients received revision 
surgeries (17%). Seven percent of papers did not describe their management 
protocols and 9% described similar management for lip repair but did not describe 
management following lip repair. In total, 15% of papers had a consistent 
management protocol within and in between experimental groups. 
 
With respect to the 11 articles that investigated a single surgeon’s practice, 8 
articles examined the effects of a passive device and 3 examined the effects of an 
active device. Three articles reported on nasolabial aesthetics, 3 reported on 
dental arch/occlusion, 1 reported on facial growth, 1 reported on dental 
arch/occlusion and growth, 2 articles reported on dental arch/occlusion and 
nasolabial aesthetics, and 1 article compared rates of revision surgeries. Six of the 
11 (55%) single-surgeon articles had inconsistent management protocols for all of 
their patients or did not specify whether the management between the control and 
experimental groups was the same. In the 5 articles that described consistent 
management protocols between groups, no study specified whether the 
treatment/control groups differed in their management following lip repair (e.g. 
palate surgery, revision surgeries etc.). Two of the 5 articles examined outcomes 
up to 4 to 6 months of age and the 3 remaining articles measured outcomes each 
at one time point between 1 to 10 years of age. On average, these articles had 
19.8 (range 13 to 42) patients in the experimental group and 29.5 (range 5 to 61) 
patients in the control group. Three articles reported improved nasolabial 
aesthetics with the use of a PSO device, 1 article reported no difference in 
nasolabial aesthetics whether or not a PSO device was used, and 1 article reported 
no difference in dental arch measurements whether or not a PSO device was used. 
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Paper  Authors Journal Year Type of 
Publication 
1 Effect of Presurgical Nasoalveolar Molding 
on Nasal Symmetry in Unilateral Complete 
Cleft Lip/Palate Patients after Primary 
Cheiloplasty without Concomitant Nasal 
Cartilage Dissection: Early Childhood 
Evaluation. 
  
Liang Z, et al. Cleft Palate-
Craniofacial Journal 
2018 Retrospective 
cohort 
2 Active presurgical infant orthopedics for 
unilateral cleft lip and palate: Intercenter 
outcome comparison of Latham, modified 
McNeil, and nasoalveolar molding. 
  
Kornbluth M, et al. Cleft Palate-
Craniofacial Journal 
2018 Retrospective 
cohort 
3 Midface Growth in Patients With Unilateral 
Cleft Lip and Palate Treated With a 
Nasoalveolar Molding Protocol. 
  
Rubin M.S, et al. The Journal of 
Craniofacial Surgery 
2019 Retrospective 
cohort 
4 The effect of nasoalveolar molding on 
nasal airway anatomy: A 9-year follow-up 
of patients with unilateral cleft lip and 
palate. 
  
Massie J.P, et al. Cleft Palate-
Craniofacial Journal 
2018 Retrospective 
cohort 
5 Burden of care of various infant orthopedic 
protocols for improvement of nasolabial 
esthetics in patients with CUCLP. 
  
Singer E, et al. Cleft Palate-
Craniofacial Journal 
2018 Retrospective 
cohort 
6 Long-term effect of presurgical 
nasoalveolar molding on growth of 
maxillary arch in unilateral cleft lip and 
palate: randomized controlled trial. 
  
Shetty V, et al. International Journal 
of Oral and 
Maxillofacial Surgery 
2017 Randomized 
controlled trial 
7 A Comparison of Mixed Dentition Dental 
Development in Cleft Patients Treated 
With and Without the Latham-type 
Appliance. 
  
Lin J, et al. Pediatric Dentistry 2017 Retrospective 
cohort 
8 Comparison of two treatment protocols in 
children with unilateral complete cleft lip 
and palate: Tridimensional evaluation of 
the maxillary dental arch. 
  
Jorge P.K, et al. Journal of Cranio-
Maxillofacial Surgery 
2016 Retrospective 
cohort 
9 Comparison of Early Onset Nasoalveolar 
Molding with Patients Who Presented for 
Molding Up to 1 Year of Age. 
Shetty V, et al. Journal of Oral and 
Maxillofacial Surgery 
2016 Randomized 
controlled trial 
10 Surgeon's and Caregivers' Appraisals of 
Primary Cleft Lip Treatment with and 
without Nasoalveolar Molding: A 
Prospective Multicenter Pilot Study. 
  
Broder H.L, et al. Plastic and 
reconstructive 
Surgery 
2016 Non-randomized 
clinical trial 
11 Presurgical orthopedics has no effect on 
archform in unilateral cleft lip and palate. 
Adali N, et al. Cleft Palate-
Craniofacial Journal 
2012 Non-randomized 
clinical trial 
12 Presurgical nasoalveolar molding 
orthopedic treatment improves the 
Sasaki H, et al. Journal of 
Craniofacial Surgery 
2012 Retrospective 
cohort 
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outcome of primary cheiloplasty of 
unilateral complete cleft lip and palate, as 
assessed by naris morphology and cleft 
gap. 
  
13 Long-term treatment outcome of 
presurgical nasoalveolar molding in 
patients with unilateral cleft lip and palate. 
Clark S.L, et al. Journal of 
Craniofacial Surgery 
2011 Retrospective 
cohort 
14 Nasoalveolar molding improves long-term 
nasal symmetry in complete unilateral cleft 
lip-cleft palate patients. 
Barillas I, et al. Plastic and 
Reconstructive 
Surgery 
2009 Retrospective 
cohort 
15 Infant orthopedics and facial growth in 
complete unilateral cleft lip and palate until 
six years of age (Dutchcleft). 
Bongaarts C.A.M, 
et al. 
Cleft Palate-
Craniofacial Journal 
2009 Randomized 
controlled trial 
16 Effect of infant orthopedics on facial 
appearance of toddlers with complete 
unilateral cleft lip and palate (Dutchcleft). 
  
Bongaarts C.A.M, 
et al. 
Cleft Palate-
Craniofacial Journal 
2008 Randomized 
controlled trial 
17 Infant orthopedics has no effect on 
maxillary arch dimensions in the 
deciduous dentition of children with 
complete unilateral cleft lip and palate 
(Dutchcleft). 
  
Bongaarts C.A.M, 
et al. 
Cleft Palate-
Craniofacial Journal 
2006 Randomized 
controlled trial 
18 Infant orthopedics and facial appearance: 
A randomized clinical trial (Dutchcleft). 
Prahl C, et al. Cleft Palate-
Craniofacial Journal 
2006 Randomized 
controlled trial 
19 The effect of infant orthopedics on the 
occlusion of the deciduous dentition in 
children with complete unilateral cleft lip 
and palate (Dutchcleft).  
Bongaarts C.A.M, 
et al. 
Cleft Palate-
Craniofacial Journal 
2004 Randomized 
controlled trial 
20 The effects of active infant orthopedics on 
occlusal relationships in unilateral 
complete cleft lip and palate. 
Chan K.T, et al. Cleft Palate-
Craniofacial Journal 
2003 Retrospective 
cohort 
21 A randomized prospective clinical trial of 
the effect of infant orthopedics in unilateral 
cleft lip and palate: Prevention of collapse 
of the alveolar segments (Dutchcleft). 
  
Prahl C, et al. Cleft Palate-
Craniofacial Journal 
2003 Randomized 
controlled trial 
22 A randomised prospective clinical trial into 
the effect of infant orthopaedics on 
maxillary arch dimensions in unilateral 
cleft lip and palate (Dutchcleft). 
  
Prahl C, et al. European Journal of 
Oral Sciences 
2001 Randomized 
controlled trial 
23 Comparison between palatal 
configurations in UCLP infants with and 
without a Hotz plate until four years of 
age. 
  
Mishima K, et al. Cleft Palate-
Craniofacial Journal 
2000 Retrospective 
cohort 
24 Quantitative 3D maxillary arch evaluation 
of two different infant managements for 
unilateral cleft lip and palate. 
Prasad C.N, et al. Cleft Palate-
Craniofacial Journal 
2000 Retrospective 
cohort 
25 Cleft lip and palate treated by presurgical 
orthopedics, gingivoperiosteoplasty, and 
lip adhesion (POPLA) compared with 
Millard D.R, et al. Plastic and 
Reconstructive 
Surgery 
1999 Retrospective 
cohort 
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previous lip adhesion method: A 
preliminary study of serial dental casts. 
  
26 Changes produced by presurgical 
orthopedic treatment before cheiloplasty in 
cleft lip and palate patients. 
  
Kozelj V Cleft Palate-
Craniofacial Journal 
1999 Retrospective 
cohort 
27 Analysis of primary gingivoperiosteoplasty 
in alveolar cleft repair. Part I: Facial 
growth. 
Henkel K.-O, et al. Journal of Cranio-
Maxillo-Facial 
Surgery 
1997 Retrospective 
cohort 
28 Morphologic effect of preoperative 
maxillofacial orthopedics (T-traction) on 
the maxilla in unilateral cleft lip and palate 
patients.  
Larson M, et al. Cleft Palate-
Craniofacial Journal 
1993 Retrospective 
cohort 
29 Craniofacial development in children with 
unilateral cleft of the lip, alveolus, and 
palate treated according to three different 
regimes. Assessment of nasolabial 
appearance. 
  
Brattstrom V, et al. Scandinavian 
Journal of Plastic 
and Reconstructive 
Surgery and Hand 
Surgery 
1992 Retrospective 
cohort 
30 Early bone grafting in complete cleft lip 
and palate cases following maxillofacial 
orthopedics. III. A study of the dental 
occlusion. 
  
Larson O, et al. Scandinavian 
Journal of Plastic 
and Reconstructive 
Surgery  
1983 Retrospective 
cohort 
31 An Intercenter Comparison of Dental Arch 
Relationships and Craniofacial Form 
Including a Center Using Nasoalveolar 
Molding. 
  
Peanchitlertkajorn 
S, et al. 
Cleft Palate–
Craniofacial Journal 
2018 Retrospective 
cohort 
32 Presurgical Nasoalveolar Molding for 
Correction of Cleft Lip Nasal Deformity: 
Experience From Northern India 
 
Mishra, et al. Open Access Journal 
of Plastic Surgery 
2010 Retrospective 
cohort 
33 A Six-Center International Study of 
Treatment Outcome in Patients with Clefts 
of the Lip and Palate: Part 4. Assessment 
of Nasolabial Appearance 
 
Asher-McDade, et 
al. 
Cleft Palate–
Craniofacial Journal 
1992 Retrospective 
cohort 
34 A Six-Center International Study of 
Treatment Outcome in Patients with Clefts 
of the Lip and Palate: Part 3. Dental Arch 
Relationships 
 
Mars, et al. Cleft Palate–
Craniofacial Journal 
1992 Retrospective 
cohort 
35 Comparative Study of Early Secondary 
Nasal Revisions and Costs in Patients 
With Clefts Treated With and Without 
Nasoalveolar Molding 
 
Patel, et al. Journal of 
Craniofacial Surgery 
2015 Retrospective 
cohort 
36 The Eurocleft Study: Intercenter Study of 
Treatment Outcome in Patients With 
Complete Cleft Lip and Palate. Part 2: 
Craniofacial Form and Nasolabial 
Appearance 
 
Brattstrom, et al. 
 
Cleft Palate–
Craniofacial Journal 
2005 Retrospective 
cohort 
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37 Postoperative Nasal Forms After 
Presurgical Nasoalveolar Molding 
Followed by Medial-Upward Advancement 
of Nasolabial Components With Vestibular 
Expansion for Children With Unilateral 
Complete Cleft Lip and Palate 
 
Nakamura, et al. Journal of Oral and 
Maxillofacial Surgery 
2009 Retrospective 
cohort 
38 The Americleft Study: An Inter-Center 
Study of Treatment Outcomes for Patients 
with Unilateral Cleft Lip and Palate Part 3. 
Analysis of Craniofacial Form 
 
Daskaloginannakis, 
et al. 
Cleft Palate–
Craniofacial Journal 
2011 Retrospective 
cohort 
39 The Americleft Study: An Inter-Center 
Study of Treatment Outcomes for Patients 
with Unilateral Cleft Lip and Palate Part 2. 
Dental Arch Relationships 
 
Hathaway, et al. Cleft Palate–
Craniofacial Journal 
2011 Retrospective 
cohort 
40 A Six-Center International Study of 
Treatment Outcome in Patients with Clefts 
of the Lip and Palate: Part 2. Craniofacial 
Form and Soft Tissue Profile 
 
Molsted, et al. Cleft Palate–
Craniofacial Journal 
1992 Retrospective 
cohort 
41 The Eurocleft Study: Intercenter Study of 
Treatment Outcome in Patients with 
Complete Cleft Lip and Palate. Part 3: 
Dental Arch Relationships 
 
Molsted, et a.  Cleft Palate–
Craniofacial Journal 
2005 Retrospective 
cohort 
Table 2: Summary of articles included in final systematic review. 
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Figure 20: Distribution of results in all articles. Positive result indicates that PSO 
device improved outcomes compared to no device and negative indicates PSO 
device worsened outcomes. 
 
 
 
 
Figure 21: Types of variability in the methodology of the reviewed studies.   
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 DISCUSSION 
 
Overall, this systematic review identified 41 studies examining the long-term 
effects of PSO device use. The primary objective of this systematic review was to 
describe the current literature on the long-term outcomes of patients treated with 
PSO devices. To this effect, the main clinical outcomes measured in these studies 
were nasolabial aesthetics, facial growth, and dental arch/occlusion. Overall, 31% 
found improved outcomes with PSO devices, 17% showed worse outcomes with 
PSO devices, and 52% found no difference in outcomes in patient treated with a 
PSO device versus no device. This large discrepancy between studies highlights 
the lack of consensus on the long-term effects of PSO device use in patients with 
cleft lip/palate. 
 
A potential reason for the discrepancy found in this systematic review is the large 
variability in management of the patients in these studies. This variability in 
management within experimental groups creates many confounding factors that 
make it difficult to draw meaningful conclusions from the results. Variability in 
patient management has previously been identified as weaknesses in cleft 
lip/palate literature but have never been quantified as was done in this review 
(35,102). In total, this review identified only 7.3% of papers had uniform 
management protocols between and within comparison groups. 
 
Identified sources of variability in patient management included different operating 
surgeons, different timing/type of lip and/or palate repair, different patients 
receiving GPP, and patients receiving different types of revision surgeries. These 
differences in management protocols are especially apparent in the Eurocleft 
studies, Americleft studies, and the Dutchcleft studies (55,56,117–120,101,110–
116). These large cohort studies were some of the earliest studies describing 
nasolabial aesthetic, dental occlusion, and facial growth outcomes in patients with 
cleft palate that received PSO device treatment. Each of these studies compared 
patients from 4 to 6 centres that all differed in the PSO device used (active versus 
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passive), type/timing of lip and palate surgery, and the surgeon that operated on 
the patients. Differing times of lip and palate repair essentially nullifies any 
comparison that can be drawn between the PSO groups because the age of the 
repair has been previously shown to affect growth (24–26). In addition, in all of 
these studies the comparison groups were each operated on by different surgeons. 
It cannot be excluded that the reported results may be a consequence of the 
operating surgeon and not the PSO device used (121). Despite being large trials, 
the variability in patient management makes it difficult to isolate and conclude how 
the PSO devices influenced patient outcomes.  
 
In an effort to eliminate some potential bias, this review also focused on studies 
from a single surgeon’s practice however, multiple confounding factors and 
methodology flaws were still identified. The review identified a total of 11 single 
surgeon studies from which 6 studies still had inconsistent management protocols 
between groups. In total, 5 single-surgeon studies had consistent management 
protocols up to the time of lip repair (57,103,121,125,137). These studies 
eliminated many confounding variables, but still had several weaknesses that 
decreased the validity of their results. All 5 studies did not report on the number of 
patients requiring further surgeries following palate repair. This is an important 
distinction that must be made when evaluating patients long-term; changes in 
clinical outcomes could be attributed to their revision surgeries instead of their 
initial management. These 5 studies were also weakened by short follow-up times 
or selection bias as described below.  
 
The 2018 paper by Liang et al. reported no overall difference in nasolabial 
aesthetics between patients that received a passive PSO device and no device. 
The strengths of this study were the consistent management protocol for each 
patient group, and the long-term (5-year) follow-up period. Unfortunately, this study 
did not comment on initial alveolar gap size/severity in the patient groups, which 
means that selection bias cannot be excluded. It is difficult to draw conclusions 
from this study without knowing if these patient cohorts started with similar alveolar 
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gap sizes. The 2011 study by Clark et al. focused on dental occlusion and 
nasolabial aesthetic analysis using 3-dimensional molds and photographs. This 
study showed no difference in occlusion or nasolabial aesthetic outcomes in 
patients treated with a passive PSO versus no PSO. The 2009 study by Barillas et 
al. was a single-surgeon study with a 9-year follow-up interval comparing nasal 
outcomes in patients treated with a passive device versus no device. This study 
found that passive devices improved nasal symmetry. The strengths and 
weaknesses of the Clark et al. and Barillas et al. studies were similar to the Liang 
et al. paper. The last two single-surgeon studies were by Adali et al. and Sasaki et 
al., both of which had follow-up periods that were less than 1 year of age. Adali et 
al. looked at the effect of an active PSO device on dental arch up to 6 months of 
age and found no difference between patients treated with an active device versus 
no device. The 2012 study by Sasaki et al. examined nasolabial aesthetics up to 
4 months of age and found improvement with passive device treatment. Overall, 
the main weakness of these final 2 single-surgeon studies was the short-term 
follow-up. These studies were less informative because they did not examine the 
changes that can occur with growth and dental development (98).   
 
This is the second retrospective review to outline long-term outcomes in patients 
with cleft lip/palate after the use of PSO devices. The first retrospective review on 
this subject examined prospective trials looking at long-term outcomes following 
PSO device use (98). This review excluded all retrospective studies and identified 
a total of 12 prospective studies. This study concluded that passive devices have 
no positive effect on motherhood satisfaction, feeding, speech, facial growth, 
dental arch, occlusion, and nasolabial aesthetics and active devices have no 
positive effects on feeding (98). Overall, the Uzel et al. review was the first to 
summarize long-term patient outcomes from PSO device use but was limited by 
the exclusion of retrospective studies. Retrospective studies form a large 
proportion of cleft palate literature, our review suggests 73% of cleft palate 
literature is retrospective in nature. Excluding retrospective studies in this field 
significantly limits the studies that can be examined. With our more recent review 
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(2019 versus 2011) and inclusion of retrospective studies, this second review is a 
more thorough and up to date systematic review than the original review done in 
2011 (98). Despite differences in the inclusion criteria of both systematic reviews, 
the overall results are similar. There is no definite conclusion on the long-term 
outcomes in patients that have received PSO treatment. Some studies identified 
detriments to growth, nasolabial aesthetics and dental arch/occlusion while others 
identified no effect or positive effects.  
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 CONCLUSION 
 
Research in the field of cleft lip and palate is greatly limited by small sample sizes 
and confounding factors such as multi-surgeon cohorts with multiple different 
protocols for patient management. This review has further highlighted the 
variability that exists in cleft palate literature. In regard to the long-term effects of 
PSO devices, there still remains no consensus on this subject. This lack of 
consensus is likely due to the multitude of confounding factors that influence the 
reported outcomes. In addition, there are very few studies actually comparing 
different types of PSO devices. The studies that do exist are also limited by 
methodological flaws. Moving forward, further research comparing active and 
passive PSO devices is warranted. In addition, confounding factors need to be 
eliminated from the comparison groups so that control and experimental groups 
are uniform in the way they are managed. Finally, these studies should match 
patients between treatment groups based on cleft severity. This would improve 
reliability of the research and resolve the differing conclusions as to how PSO 
devices affect long-term facial growth, dental arch development, and nasolabial 
aesthetics. 
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Chapter 3: 10-Year Nasolabial Aesthetic Comparison in Patients with 
Different Pre-surgical Orthopedic Devices 
 
Long-term outcomes in patients with cleft palate that are treated with different pre-
surgical orthopedic devices are still highly debated. There is no consensus in the 
literature about the long-term effects of these devices on nasolabial aesthetics, 
and there is minimal research comparing the effects of different types of devices. 
The purpose of this chapter was to evaluate the 10-year nasolabial aesthetic 
outcomes in patients treated with active or passive pre-surgical orthopedic devices 
and patients treated with no device.   
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 INTRODUCTION 
 
The management of patients with cleft lip and palate (CL/P) is a multi-staged, multi-
disciplinary process (34). The overall objective of treating patients with CL/P is to 
give them a functional lip and palate with good aesthetic results (32,33). Pre-
surgical orthopedic (PSO) devices are a possible management option used to 
decrease the size of the alveolar gap, but have also been shown to possibly 
improve aesthetic outcomes (52). Pre-surgical orthopedic devices can be active or 
passive. Active PSO devices consist of a pin-retained appliance that is adjusted 
daily to drive the edges of the alveolar gap closer together, whereas passive 
devices are gradually molded to bring the respective nasal and alveolar elements 
closer together (35).  
 
A significant reported benefit of PSO device use is improved nasolabial aesthetics 
(52). Several studies have shown improved nasolabial aesthetics with active and 
passive devices compared to patients who did not receive PSO device treatment 
(35,51,52,128). Specifically, passive devices have been shown to improve alar 
base symmetry, vermillion symmetry, and columellar lengthening/deviation 
(138,139). While studies have shown that active devices have positive effects on 
overall nasolabial aesthetics, no specific effects have been described (35).  
Conversely, there are also studies that show no improvement in nasolabial 
aesthetics with the use of a PSO device (103,116). Ultimately, there is no 
consensus in the literature about the effect of PSO devices on nasolabial 
aesthetics.  
 
In addition to a lack of consensus on the specific effects of PSO devices on 
nasolabial aesthetics, the research that is published on this subject is limited by 
small sample sizes and confounding factors that limit the generalizability of the 
results (35,52,102,109). Confounding factors include multiple operating surgeons, 
different surgical protocols, different rates of revision surgery, and varying degrees 
of cleft severity between comparison groups. These confounding factors make it 
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difficult to draw conclusions about the effects of the PSO device on nasolabial 
aesthetics. In addition to a lack of consensus on the effect of PSO devices on 
nasolabial outcomes, there are few studies comparing the long-term patient 
outcomes between patients treated with different types of PSO devices (35). These 
studies are limited because centres often do not use both active and passive 
devices, so the outcomes are rarely compared.  
 
In conclusion, a study comparing the long-term effects of active and passive PSO 
devices on nasolabial aesthetics is required. The objective of this research chapter 
was to compare nasolabial aesthetic outcomes in patients from a single surgeon’s 
cohort treated with an active PSO device, passive PSO device, or no device over 
a 10-year period.   
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 METHODOLOGY 
 
All patients in this study were treated by a cleft palate team that has a single cleft 
palate surgeon, a single orthodontist, and a single speech language pathologist 
involved in the care of every patient. At our institution patients and their families 
are offered treatment with a PSO device at approximately 2 weeks of age if their 
alveolar gap is greater than 4mm. The decision as to whether an active or a 
passive device is used is based on caregiver preference and capacity to manage 
the device. Patients undergo a modified Mohler lip repair at approximately 3 
months and a palatoplasty at approximately 12 months. Patients and their families 
are also offered lip revision surgery if either the surgeon or caregiver are 
concerned about the aesthetics or functionality of the lip repair. Lip revision surgery 
is offered at any time during management and involves a total takedown and redo 
of the lip repair.  
 
A retrospective review of all patients with cleft lip and palate in a single surgeon’s 
practice from 2002-2018 was performed. All patients with a unilateral complete or 
incomplete cleft of the primary palate were identified. Patients were excluded if 
they had a known syndrome, bilateral cleft lip or palate, or were not operated on 
by the primary surgeon. Patients were divided into 3 groups based on whether they 
received pre-surgical care with an active PSO device, a passive PSO device, or 
no PSO device. The following basic patient demographic information was collected 
through a chart review: (1) involvement of primary and secondary palate, (2) side 
of cleft, (3) smoking mother, (4) family history of cleft lip or palate, (5) use of pre-
surgical taping, (6) age of active device insertion (if applicable), (7) age of lip and 
palate repair, (8) type of lip and palate repair, and (9) lip revision surgery. 
 
Initial patient measurements including anterior vertical alveolar gap (AG), anterior 
horizontal AG, palate width at the level of the posterior hard palate, cleft width at 
the level of the posterior hard palate, and bilateral alar base measurements were 
recorded (Figure 22). These measurements were recorded at 3 time points: device 
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insertion, lip repair, and palate repair. Patients with no device did not have 
measurements taken until the time of lip repair. Patients with a device had their 
initial measurements performed on plaster molds that are taken intra-orally at the 
time of their initial visit. These molds were measured by a single blinded reviewer 
using electronic calipers to the nearest 1/100 of a millimeter. Measurements were 
repeated on 10 patients at 3 separate occasions within 1 month to measure intra-
rater reliability. Alar base measurements were recorded only at the time of lip repair 
and posterior palate/cleft width were recorded only at the time of palate repair. 
Measurements at the time of lip and palate repair are recorded intra-operatively by 
the primary surgeon using calipers (to the nearest 1/10 of a millimeter) and are 
recorded in the patient chart. No intra-rater reliability measurements were 
performed on the surgeon’s measurements as they were considered to be the 
standard for measurements. 
 
 
 
Figure 22: Recorded cleft palate landmarks. A/A': antero-medial edge of hard 
palate (non-cleft and cleft side); B/B': postero-medial edge of hard palate (non-cleft 
and cleft side); C/C': postero-lateral edge of hard palate (non-cleft and cleft side); 
V: vertical alveolar gap; H: horizontal alveolar gap. 
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 Nasolabial Aesthetics 
 
Photographs are taken at every patient follow-up visit and kept in patient charts. 
Patient photographs were digitized and evaluated by a single blinded reviewer. 
Worms view and frontal view photographs were used for analysis. All photographs 
were cropped to show only the patient’s nose and lips. All other facial features 
were excluded. Each photograph was evaluated using a validated 11-point scale 
(APPENDIX 2- NASOLABIAL AESTHETIC RATING SCALE). Features 
evaluated in the nasolabial scale included: (1) nasal tip symmetry, (2) nostril 
circumference, (3) nostril rim symmetry, (4) recurvatum of nostril, (5) columella 
angulation, (6) Cupid’s Bow, (7) vermillo-cutaneous junction, (8) vermillo-mucosal 
junction, (9) alar base symmetry, (10) scar position, and (11) scar quality (Figure 
7). Each specific nasolabial feature was graded as “favorable” or “unfavorable”. If 
the rater was unable to determine whether the result was favorable or unfavorable 
the section was left blank and excluded from analysis. A subset of 20 randomly 
selected photographs were analysed a total of 3 separate times over the course of 
1 month to calculate intra-rater reliability.  
 
 
1.3.1 Statistical Analysis  
 
For comparing demographic information, chi square tests were used. For 
comparing palatal/lip measurements one-way ANOVA was used. For both 
comparisons a p value of less than 0.05 was considered to be significant. For 
statistical analysis of nasolabial aesthetics, a chi square test was done for all 11 
questions comparing the number of favorable versus unfavorable outcomes. 
Fischer’s exact test was used if the number of cases in a group was less than 5. 
Bonferroni correction was used to correct for multiple comparisons for the 
nasolabial aesthetics; a p of less than 0.005 was considered significant based on 
this correction. Cohen’s kappa coefficient was used to calculate intra-rater 
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reliability for all categorical measurements. All statistical comparisons were 
calculated using IBM SPSS ™ software.  
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 RESULTS 
 
1.4.1 Patient Demographics 
 
A total of 104 patients were included in this study; 39 patients received treatment 
with an active device, 31 patients received treatment with a passive device, and 
34 patients did not receive treatment with a PSO device. The active device was 
inserted at an average age of 2.2 months.  Table 3 outlines the remaining 
demographic information for the study population. Age at cheiloplasty was 
significantly different between the three groups (p<0.01), but there was no 
statistical difference in the age that patients had palatoplasty (p=0.89). The rate of 
lip revision in the active, passive, and no device groups was as follows: 7.69% 
active, 32.3% passive, 14.7% no device (p=0.03). Otherwise, there was no 
statistical difference between the groups for the remaining demographic variables. 
 
Table 4 outlines measurements for vertical AG, horizontal AG, palate width at 
posterior hard palate, cleft width at posterior hard palate, and alar base width of 
the cleft and non-cleft side for all 3 groups. For initial vertical and horizontal alveolar 
gap measurements there was a significant difference between the groups (p<0.01, 
p<0.01); patients with no device had smaller gaps than patients with an active 
(p<0.01, p<0.01) or a passive device (p=0.01, p<0.01). For initial cleft and non-
cleft side alar base measurements there was a significant difference between the 
groups (p<0.01, p<0.01); patients with no device had smaller cleft-side and non-
cleft side alar base measurements than patients with an active (p<0.01, p=0.02) or 
a passive device (p<0.01, p=0.01). At the time of lip repair non-cleft side alar base 
measurements were similar (p=0.24), but different on the cleft side (p<0.01). 
Vertical AG was similar between the 3 groups at lip repair (p=0.11) and palate 
repair (p=0.54). Horizontal AG was significantly different at lip repair (p<0.01) but 
not significantly different at the time of palate repair (p=0.54). Posterior cleft width 
and palate width were not statistically different between the three groups at palate 
repair (p=0.15, p=0.29). There was no significant difference between patients who 
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received or did not receive a lip revision surgery based on the size of their 
horizontal or vertical alveolar gap at the initial visit (p= 0.17, p= 0.07) or at lip repair 
(p= 0.38, p= 0.57). 
 
 
1.4.2 Intra-rater Reliability 
 
Intra-rater reliability measurements were calculated for all of the initial AG 
measurements. Intra-class correlation coefficient values were over 0.90 for all 
alveolar gap measurements which indicates excellent intra-rater reliability.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Active PSO 
n= 39 
Passive PSO 
n= 31 
No PSO 
n= 34 
P value 
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Basic 
Demographic 
Information 
M:F 
L:R Sided Clefts 
Family History 
Smoking Mother 
27:12 
25:14 
16/31 
5/22 
19:12 
20:11 
7/24 
5/20 
22:10 
17:16 
6/18 
6/13 
0.78 
0.47 
0.20 
0.34 
Cheiloplasty Age  
Lip Adhesion 
4.3 months 
0 Lip adhesion 
5.2 months 
2 Lip adhesion 
3.9 months 
2 Lip adhesion 
<0.01 
 
Palatoplasty Age  
Surgery 
12.3 months 
34 Hybrid 
3 Furlow 
2 Unknown 
12.1 months 
18 Hybrid 
6 Furlow 
7 Unknown 
12.2 months 
13 Hybrid 
4 Furlow 
17 Unknown 
0.89 
0.15 
 
 
Lip Revision Yes:No 
Reason for 
revision 
 
1:38 
1 Scar >3mm  
9:22 
2 Hyper. scar 
5 Scar >3mm 
1 Ala narrow 
1 Unknown 
5:21 
1 Hyper. scar 
4 Scar >3mm 
0.03 
 
Table 3: Demographic information for study cohort. M=male, F= female, L= left, 
R=right, Hyper= hypertrophic  
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  Active PSO 
n= 39 
Passive PSO 
n= 31 
No PSO 
n= 24 
P 
value 
Initial (mm) Vertical AG 
Horizontal AG 
Alar Base (Cleft) 
Alar Base (Non-Cleft) 
9.44 
6.16 
15.8 
6.10 
7.43 
6.18 
14.1 
7.66 
3.93 
1.89 
11.1 
5.02 
<0.01 
<0.01 
<0.01 
<0.01 
Lip Repair 
(mm) 
Vertical AG 
Horizontal AG 
Alar Base (Cleft) 
Alar Base (Non-Cleft) 
5.08 
2.70 
16.1 
4.98 
7.23 
7.26 
13.0 
5.40 
3.93 
1.89 
11.1 
5.02 
0.11 
<0.01 
<0.01 
0.24 
Palate 
Repair 
(mm) 
Vertical AG 
Horizontal AG 
Palate Width 
Posterior Cleft Width 
2.26 
0.59 
29.1 
11.7 
2.90 
2.54 
29.9 
9.57 
1.73 
0.15 
30.8 
6.13 
0.54 
0.09 
0.29 
0.15 
Table 4: Alveolar gap measurements for patient cohort.  
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1.4.3 Nasolabial Aesthetics 
 
The following patients had photographs for nasolabial aesthetic assessment at the 
1-year mark: 31 active device, 30 passive device, and 31 patients with no device. 
At the 1-year mark there was no significant difference between the 3 groups for 
any of the 11 nasolabial outcomes measured (Figure 23). Age that the 
photographs were taken was also not significantly different between the 3 groups 
at the 1-year mark (p=0.25). At the 5-year mark the following patients had 
photographs for analysis: 30 active device, 23 passive device, and 26 patients with 
no device. There was no significant difference between the 3 groups for nasolabial 
aesthetics or age of the photographs at the 5-year mark (Figure 24). At the 10-year 
mark the following patients had photographs for analysis: 18 active device, 24 
passive device, and 22 patients with no device. There was no significant difference 
between the groups for nasolabial aesthetics at the 10-year mark (Figure 25). 
There was a significant difference in the age that photographs were taken; patients 
with an active device had photos taken at an average of 8.59 years, patients with 
a passive device had photos at 9.77 years, and patients with no device had photos 
at 9.75 years (p<0.01). When all 11 variables were combined into an overall score, 
there was no significant difference between the 3 groups at the 1-year, 5-year, or 
10-year mark (Figure 26, Table 5). 
 
 
1.4.4 Sub-group Analysis 
 
A separate analysis was also performed to control for the different rates of lip 
revision between the 3 groups. A repeat analysis was performed with all patients 
who received lip revision surgery excluded. There was no significant difference 
between the 3 groups for any nasolabial aesthetic measurements at the 1-year, 5-
year, or 10-year mark.  
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1.4.5 Intra-rater Reliability 
 
Intra-rater reliability was calculated using Cohen’s kappa coefficient. Kappa 
coefficient was 0.791 which indicates substantial intra-rater reliability.  
 
 
 
 
Figure 23: Percent favorable outcomes for each question of the nasolabial 
aesthetic scale at the 1-year mark. 
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Figure 24: Percent favorable outcomes for each question of the nasolabial 
aesthetic scale at the 5-year mark. 
 
 
 
Figure 25: Percent favorable outcomes for each question of the nasolabial 
aesthetic scale at the 10-year mark.  
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Figure 26: Percent Overall Favorable Nasolabial Outcomes. 
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  Active PSO 
n= 39 
Passive PSO 
n= 31 
No PSO 
n= 34 
P 
Value 
Subgroup 
Analysis 
1-Year  N  
Age (years) 
Overall Outcome 
31 
1.34 
69.6% 
30 
1.08 
70.9% 
31 
1.14 
72.1% 
  
0.08 0.25 
0.80 0.39 
5-Year  N 
Age (years) 
Overall Outcome 
Growth 1 to 5 Yr 
30 
4.23 
68.5% 
+1.04% 
23 
5.15 
71.1% 
+0.84% 
26 
4.86 
70.2% 
+0.40% 
  
0.06 0.15 
0.82 
1.00 
0.52 
 
10-Year  N 
Age (years) 
Overall Outcome 
Growth 5 to 10 Yr 
18 
8.59 
77.5% 
+5.58% 
24 
9.77 
71.2% 
+1.86% 
22 
9.75 
76.1% 
+4.78% 
  
<0.01 0.03 
0.21 
0.80 
0.62 
 
Table 5: Percent favorable outcomes and growth between groups at 1, 5, and 10 
years. Subgroup analysis excluded patients with lip revision surgery. 
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 DISCUSSION 
 
The long-term effects of PSO devices on nasolabial aesthetics are still highly 
debated. The current literature that exists is limited by patient groups that are 
operated on by different surgeons using different protocols. This variability limits 
the conclusions that can be drawn from this research. This study is the first single-
surgeon study to examine the long-term effects of PSO devices on nasolabial 
aesthetics in patients whose management protocol only differed based on which 
PSO device was used.  
 
In this study, nasolabial aesthetics were compared between patients treated with 
an active PSO device, a passive PSO device, and patients treated without a PSO 
device. All 3 patient groups had similar demographic factors. Patients that were 
treated with a passive device had lip repair surgery performed later than the other 
2 groups. This is an expected finding; passive devices take longer to re-
approximate the edges of the alveolar gap which does delay lip repair. All 3 groups 
had palate repair at the same time (range 12.1 to 12.3 months) and a similar 
distribution of types of palate repair. Patients treated with PSO devices had initially 
larger vertical and horizontal alveolar gaps as well as cleft and non-cleft side alar 
base measurements compared to patients without a device. This is also an 
expected finding; patients with more severe alveolar gaps are the ones that are 
offered a PSO device. Specifically, patients treated with a passive device had 
larger horizontal AG measurements at lip repair. This may be secondary to the fact 
that passive devices mold the alveolar elements and do not drive them together 
like the active device does. Secondly, patients treated with an active device had 
larger cleft-side alar base measurements at lip repair. This difference may be due 
to the lack of nasal molding associated with active devices; passive devices have 
a nasal molding component while active devices do not. Despite these initial 
differences between groups, by the time of palate repair there was no significant 
difference in the size of the AG in all 3 groups.  
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Patients with passive devices had higher rates of lip revision surgery compared to 
patients with active devices or no device. The majority of patients had a lip revision 
over concerns for scarring, specifically a hypertrophic or wide scar. The decision 
to undergo revision is usually a joint decision between the surgeon and the 
patient’s family. There was no record of whether these patients underwent scar 
revision due to suggestion from the family or the surgeon. This makes it difficult to 
comment on whether patients and their families were dissatisfied with the scarring 
outcomes. One possible explanation for the higher rates of lip revision surgery in 
patients treated with a passive device may be that the larger horizontal AG at the 
time of lip repair made the repair more challenging. A tighter repair could have led 
to more tension on the closure and higher rates of dehiscence. Despite this 
possible explanation, a wider AG at lip repair was not associated with increased 
risk of lip revision surgery. Since scarring was not found to be significantly different 
between the 3 groups and increased AG width was not found to be associated with 
higher rates of scar revision, other factors that were not described in this study are 
likely the cause of the difference in the rate of scar revision between the groups. 
 
Looking specifically at the nasolabial outcomes, all aspects of the nasolabial 
assessment were similar between the 3 groups at the 1-year, 5-year, and 10-year 
mark. Sub-group analysis eliminating all patients that received a lip revision 
surgery was also performed to ensure that lip revision was not a confounding 
factor. There was no change in the significance of the results which indicates that 
lip revision did not confound the nasolabial aesthetic findings.  Overall, the 
similarity in nasolabial aesthetics between these 3 groups indicates that despite 
starting with different alveolar gap sizes, patients treated with PSO devices have 
comparable nasolabial aesthetic up to 10 years of age.  
 
Looking specifically at the comparison between patients treated with active or 
passive PSO devices, it is important to recognize that there was no difference in 
nasal outcomes (e.g. columellar deviation, nasal recurvatum) between the 2 
groups. Passive molding devices have previously been shown to improve nasal 
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outcomes including columellar deviation/height and alar base symmetry (35,139). 
These supposed nasal benefits are a motivating factor for the use of a passive 
device over an active device (140). However, the results of this study indicate that 
the passive device does not achieve superior nasal outcomes compared to the 
active device. 
 
Overall, PSO devices were used in our patient population for patients with more 
severe AGs. Based on the results of this current study, active and passive PSO 
devices give patients with more severe AGs nasolabial aesthetic outcomes that 
are comparable to patients with less severe AGs. Furthermore, this study showed 
that passive molding does not provide superior nasal aesthetic outcomes 
compared to molding with an active device. Moving forward, a prospective study 
comparing these 3 groups matched for AG severity would determine whether PSO 
devices help achieve superior nasolabial aesthetics compared to patients with 
similar clefts treated without a device.  
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 CONCLUSION 
 
Overall, the objective of this study was to compare nasolabial aesthetics between 
patients treated with active or passive PSO devices to those treated without a PSO 
device up to 10 years of age. The results of this study show that patients treated 
with a PSO device start with larger AGs, but the PSO device is able to decrease 
the AG to a size that is similar to a less severe or incomplete cleft. In addition, 
treatment with PSO devices gives patients starting with more severe AGs 
nasolabial aesthetics that are comparable to patients with less severe AGs that do 
not require PSO treatment. Finally, this study found that passive PSO devices are 
not superior to active devices for nasal aesthetics despite having a nasal molding 
component. Moving forward, a prospective study that compares the use of passive 
and active PSO devices to patients with no device that are matched for cleft 
severity would elucidate whether PSO devices directly improve nasolabial 
aesthetics, or whether aesthetics are dependent on other factors.  
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Chapter 4: 10-Year Dental Occlusion and Facial Growth Comparison in 
Patients Treated with Different Pre-surgical Orthopedic Devices  
 
Long-term outcomes in patients with cleft palate that are treated with different pre-
surgical orthopedic devices are still highly debated. There is no consensus in the 
literature about the long-term effects of these devices on dental occlusion and 
facial growth, and there is very little literature comparing different types of these 
devices. The purpose of this chapter is to evaluate and compare 10-year dental 
occlusion and facial growth in patients treated with active or passive pre-surgical 
orthopedic devices.  
 
A portion of this work was presented at the Canadian Society of Plastic Surgeons 
(CSPS) 2020 annual meeting. 
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 INTRODUCTION 
 
A controversial topic in cleft lip/palate (CL/P) management is the use of pre-
surgical orthopedic (PSO) devices. Broadly, PSO devices can be classified as 
either active or passive devices. Passive devices bring the edges of the alveolar 
gap closer together through the use of custom palatal molds (with or without nasal 
stents), while active devices use pins and screws to reapproximate the edges of 
the gap through active movement (35).  Pre-surgical orthopedic devices were 
initially designed to be used in conjunction with gingivoperiosteoplasty (GPP) to 
reduce the size of the alveolar gap and create a more anatomic dental arch (35). 
Previous research has shown that active PSO devices in conjunction with GPP 
lead to decreased maxillary growth (44). Many surgeons have moved away from 
using GPP in conjunction with an active PSO device, but the effect of the active 
PSO device alone is still debated (54,123). Unlike research on active devices, to 
date there do not appear to be any studies that have looked at facial growth in 
patients treated with a passive device and GPP. Furthermore, the studies that have 
looked at facial growth outcomes in patients treated with a passive device alone 
show that the device has no effect on growth (114,126).  
 
Given these differences reported in the literature, an important comparison that 
should be made is between patients receiving different types of PSO devices. 
There is currently very minimal research comparing different types of PSO devices 
(35). There is no consensus as to the effects of either of these devices on dental 
occlusion and growth. In addition, there are very few research publications actually 
comparing these two types of devices. Both of these types of devices have 
negatives and positives to their use; active devices require an additional anesthetic 
for insertion of the device while passive devices take longer to mold the palate 
(35). This comparison is important for determining if one device is superior to the 
other for reducing negative effects on facial growth and dental occlusion and would 
help guide practice moving forward.  
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At our institution, the same surgeon and orthodontist have treated a cohort of 
patients with CL/P for over 15 years. Both active and passive molding devices are 
offered to patients and their families. This presents the unique opportunity to 
compare outcomes in patients whose management only differs in the PSO device 
that they received. The objective of this research chapter is to compare the effects 
of active PSO devices and passive PSO devices on dental occlusion and facial 
growth in a single-surgeon’s cohort of patients with CL/P over a 10-year period.   
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 METHODOLOGY 
 
A retrospective review of all patients with cleft lip and palate in a single surgeon’s 
practice from 2002-2018 was performed. This cohort of patients was under the 
management of a multidisciplinary cleft palate group that consisted of a single 
palate surgeon, a single orthodontist, and a single speech language pathologist. 
All patients with a unilateral complete cleft of their primary palate treated with an 
active or passive pre-surgical device were identified. Patients were excluded if they 
had no molds or cephalograms taken, were not treated with a PSO device, had a 
known syndrome, had bilateral cleft lip or palate, or were not operated on by the 
primary surgeon. Patients were divided into two groups based on whether they 
received pre-surgical care with an active PSO device or a passive PSO device. 
Basic patient demographic information and initial alveolar gap measurements were 
collected as described in CHAPTER 0. Additional demographic patient information 
that was recorded for this study included patients who received bone graft surgery, 
were diagnosed with velopharyngeal insufficiency (VPI), or had treatment with 
braces/elastics and protraction face masks. Patients were excluded from 
calculation of the rate of braces application and bone graft surgery if they were 
under the age of 8 as these patients are too young for such treatments. 
 
 
1.2.1 Dental Occlusion 
 
Patient molds are taken at each patient visit; these molds are plaster casts of the 
maxillary and mandibular dentition (Figure 9). All patient molds were evaluated and 
measured by a single blinded reviewer. A subset of 20 randomly selected molds 
were analysed a total of 3 separate times over the course of 1 month to calculate 
intra-rater reliability. Dental occlusion was assessed by putting molds in anatomic 
alignment and measuring occlusion based on the Angle classification (Figure 8), 
GOSLON Yardstick classification (Figure 9), Modified Huddart Bodenham (MHB) 
classification (Figure 10), and dental arch measurements (Figure 11).  
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The Angle classification was assessed using the bilateral molars; the second molar 
was used to calculate the Angle score for primary dentition and the first molar was 
used to calculate the Angle score for mixed/permanent dentition. For classifying 
Angle occlusion, half a cusp of anterior or posterior displacement was considered 
abnormal and qualified as Grade 2/3. If the Angle scores on the left and right side 
differed, the more severe occlusal grade was recorded for each mold.  
 
The GOSLON Yardstick classification was assessed by measuring the overjet 
between the upper and lower central incisors with a boley gage to the nearest 1/10 
of a millimeter. Occlusion was then graded based on the amount of overjet 
measured. Overall GOSLON yardstick grade and overjet (in millimeters) were 
recorded for each mold.  
 
Overall grade for the MHB classification was calculated as the sum of each 
individual grade. If a maxillary tooth was missing for MHB analysis, the grade was 
assessed by using the position of the mandibular tooth compared to the midpoint 
of the maxillary arch. If the maxillary and the corresponding mandibular tooth were 
both missing, the average MHB grade of the two surrounding teeth was used.  
 
Dental arch measurements were measured as described in CHAPTER 0 using 
electronic calipers to the nearest 1/100 of a millimetre. Dental arch measurements 
included inter-canine width (ICW), inter-palatal molar width (IPMW), and the sum 
of the incisors (SI). If a maxillary tooth required for measurement was missing, the 
measurement was taken from the centre of the alveolar arch in line with the 
corresponding contralateral tooth. 
 
 
1.2.2 Cephalometric Analysis  
 
Patient radiographs are taken at 5 and 10 years during their follow-up visits. These 
radiographs were digitized and analysed using the Dolphin Imaging™ 
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cephalometric software. Each cephalogram was standardized for magnification 
using a 40mm ruler included in each radiograph. Standard cephalometric 
landmarks were plotted by 2 reviewers who reached a consensus about the 
placement of each plotted landmark. Each radiograph was analyzed in a random 
order. A subset of 10 randomly selected radiographs were analysed on 3 separate 
occasions over the course of 1 month to calculate intra-rater reliability. 
Cephalometric measurements were derived from the plotted landmarks; the 
Dolphin Imaging™ program calculates cephalometric measurements based on 
these plotted landmarks. Table 1 describes each of the cephalometric 
measurements that were calculated by Dolphin Imaging™. Overall, maxillary, 
mandibular, vertical, dento-alveolar, and soft tissue landmarks were calculated. 
 
 
1.2.3 Statistical Analysis  
 
For statistical analysis, mean Angle score, GOSLON yardstick score, MHB score, 
and dental arch measurements were compared between the 2 groups using an 
independent sample t-test. Fischer’s exact test was used to compare the 
distribution of patients with each Angle score and GOSLON yardstick score. 
Changes in occlusion and dental arch were also calculated for all patients that had 
5 and 10-year measurements. This was calculated as the 10-year measurement 
minus the 5-year measurement. The means of these growth measurements were 
also compared via independent sample t-tests. Bonferroni correction was used to 
correct for multiple comparisons of occlusion. 
 
For cephalometric measurements, measurements for patients with an active PSO 
versus a passive PSO were calculated using independent sample t-tests. Growth 
changes were also calculated for all patients that had 5-year and 10-year 
cephalometric measurements. Growth was calculated as the 10-year 
cephalometric measurement minus the 5-year cephalometric measurement. The 
means of these growth measurements were also compared via independent 
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sample t-tests. Bonferroni correction was used to correct for multiple comparisons 
of cephalometric measurements. 
 
Intra-class correlation coefficient (ICC) was calculated for intra-rater reliability of 
all measured values. Cohen’s kappa coefficient was used to calculate intra-rater 
reliability for all categorical measurements. All statistics were calculated using IBM 
SPSS ™ software.  
 
 
.  
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 RESULTS 
 
1.3.1 Demographic Information 
 
Twenty patients with an active device and 23 patients with a passive device were 
included in this study. No differences were observed in the male/female 
distribution, left/right-sided cleft distribution, risk factors for cleft development, age 
and type of lip repair, age and type of palate repair, use of face masks, use of 
braces, rate of lip revision surgery, rate of bone grafting, and rate of VPI 
development between experimental groups (Table 6). Cleft measurements, alar 
base measurements, and palatal width measurements were statistically 
insignificant between the two groups at their initial visits. At the time of lip repair, 
patients with a passive device had significantly larger horizontal alveolar gaps but 
smaller cleft-sided alar base measurements (p<0.01, p<0.01). At the time of palate 
repair, the difference in anatomic measurements between the two groups was 
insignificant (Table 7).  
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  Active PSO 
n= 20 
Passive PSO 
n= 22 
P value 
Basic 
Demographic 
Information 
M:F 
L:R Sided Clefts 
Family History of Cleft 
Smoking Mother 
14:6 
13:7 
41.2% 
33.3% 
14:8 
13:9 
33.3% 
18.8% 
0.75 
0.69 
0.63 
0.66 
Cheiloplasty Age  
Surgery 
 
 
Lip Adhesion 
4.5 months 
20 Mohler 
0 Millard 
0 Unknown 
0 Lip adhesion 
5.1 months 
18 Mohler 
2 Millard  
1 Unknown 
1 Lip adhesion 
0.29 
0.49 
 
 
Palatoplasty Age  
Surgery 
12.3 months 
19 Hybrid 
1 Furlow 
0 Unknown 
12.0 months 
12 Hybrid 
5 Furlow 
5 Unknown 
0.59 
0.08 
 
 
Braces/Elastics Yes:No:N/A 6:5:9 14:8 0.46 
Face Masks Yes:No 1:19 6:16 0.10 
Lip Revision Yes:No 2:18 7:15 0.07 
Bone Graft Yes:No:N/A 7:4:9 19:2:1 0.15 
VPI Yes:No:N/A 4:7:9 5:16:1 0.68 
Table 6: Basic demographic information for experimental groups. VPI= 
velopharyngeal insufficiency. N/A indicates patient too young to assess. 
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Active PSO 
n= 20 
Passive PSO 
n= 22 
P value 
Initial 
Measurements 
(mm) 
  
Vertical AG 
Horizontal AG 
Palate Width 
Posterior Cleft Width 
Alar Base (Cleft) 
Alar Base (NC)  
9.37 
6.28 
29.8 
15.6 
15.6 
6.22 
7.25 
6.46 
28.9 
16.2 
14.0 
8.04 
0.16 
0.87 
0.48 
0.66 
0.21 
0.05 
Lip Repair 
Measurements 
(mm) 
Vertical AG 
Horizontal AG 
Alar Base (Cleft) 
Alar Base (NC) 
5.10 
3.15 
16.5 
5.24 
8.19 
9.97 
11.9 
5.56 
0.06 
<0.01 
<0.01 
0.36 
Palate Repair 
Measurements 
(mm) 
Vertical AG 
Horizontal AG 
Palate Width 
Posterior Cleft Width 
1.75 
0.66 
30.8 
14.4 
4.00 
1.00 
29.9 
10.5 
0.41 
0.94 
0.38 
0.58 
Table 7: Anatomic measurements for assessing cleft severity at initial visit, lip 
repair, and palate repair. NC= non-cleft side 
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1.3.2 Dental Arch and Occlusion 
 
For the 5-year dental analysis, 20 patients with an active device and 20 patients 
with a passive device had molds for analysis. There was no significant difference 
in the average Angle classification, MHB classification, and GOSLON yardstick 
classifications between the three groups (p=0.86, p=0.74, p=0.73) (Table 8). 
Average Angle classification was: 2.15 for the active group and 2.20 for the passive 
group. All 3 patient groups showed no statistical difference in the number of 
patients with Angle class 1, 2, or 3 classification (p=1.00) (Figure 27). Average 
MHB classification was -7.50 for the active group and -6.85 for the passive group 
(p=0.74). Average GOSLON yardstick classification was: 3.20 for the active group 
and 3.15 for the passive group (p=0.73). Both patient groups showed no statistical 
difference in the number of patients with GOSLON yardstick class 1, 2, 3, 4, and 
5 occlusion (p=0.79) (Figure 28). Average amount of central incisor overjet was      
-0.07mm for the active group and 0.12mm for the passive group (p=0.82). Average 
inter-canine and inter-palatal molar width for each group was: 25.7mm and 
35.0mm for the active group, and 25.9mm and 33.8mm for the passive group 
(p=0.81, p=0.45). Average sum of incisor measurements was: 21.7mm and 
21.9mm for the active and passive groups respectively (p=0.79) (Table 9). Average 
age of device measurement was 5.60 years in the active group and 6.24 in the 
passive group (p=0.05). 
 
For the 10-year dental analysis 15 patients with an active device and 22 patients 
with a passive device had molds for analysis. There was no significant difference 
in the Angle classification, MHB classification, and GOSLON yardstick 
classifications between the two groups (p=0.93, p=0.58, p=0.13) (Table 8). 
Average Angle classification was: 2.07 for the active group and 2.05 for the passive 
group (p=0.93). Patients with an active PSO device and a passive PSO device had 
no statistical difference in the distribution of patients with Angle class 1, 2, and 3 
classification (p=0.35) (Figure 29). Average MHB classification was -6.43 for the 
active group and -5.41 for the passive group (p=0.58). Average GOSLON yardstick 
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classification was: 3.00 for the active group and 2.59 for the passive group 
(p=0.13). There was no significant difference in the distribution of patients with 
GOSLON yardstick class 1, 2, 3, 4, and 5 occlusion (p=0.14) (Figure 30). Average 
amount of central incisor overjet was: 0.70mm in active patients and 0.40mm in 
passive patients (p=0.73). Average inter-canine and inter-palatal molar width for 
each group was: 28.5 mm and 42.7mm for the active group, and 29.8mm and 
40.3mm for the passive group (p=0.41, p=0.10). Average sum of incisor 
measurements was: 24.0mm and 26.2mm for the active and passive groups 
respectively (p=0.14) (Table 9). Average age of device measurement was 9.37 
years in the active group and 9.95 in the passive group (p=0.18). 
 
 
1.3.3 Change in Dental Arch Relationships and Occlusion from Five to Ten 
Years 
 
Fifteen patients from the active device group and 19 patients from the passive 
device group had 5-year and 10-year molds for evaluation of changes over the 5-
year period (Figure 31). Average change in Angle classification from 5 to 10 years 
was -0.33 for active device patients and -0.26 for passive device patients (p=0.87). 
Change in MHB classification was 0.80 for active device patients and 2.11 for 
patients with a passive device (p=0.57). The change in GOSLON yardstick scoring 
for the groups was -0.27 for the active group and -0.79 for the passive device 
(p=0.31). Change in overjet was 0.85mm for active device patients and 0.48mm 
for passive device (p=0.77). Change in inter-canine width for patients was not 
significant (p=0.12). Change was 2.15mm for patients with an active device and 
4.58mm for patients with a passive device. Change in inter-palatal molar width for 
active and passive device patients was 7.06mm and 6.72mm respectively 
(p=0.82). Finally, change in sum of incisors for active and passive device patients 
was 1.83mm and 4.70mm respectively (p=0.07).  
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1.3.4 Intra-rater Reliability 
 
Intra-rater reliability was calculated using Cohen’s kappa coefficient for Angle 
classification and GOSLON yardstick classification. The kappa value for intra-rater 
reliability of the Angle classification and GOSLON yardstick was 0.53 and 0.80 
which represent moderate and substantial intra-rater reliability. Intra-class 
correlation coefficient was used to calculate intra-rater reliability for MHB 
classification, overjet, ICW, IPMW, and SI. The ICC was 0.88 for MHB which 
indicates good intra-rater reliability. The ICC was 0.86 for overjet measurements 
which indicates good intra-rater reliability. The ICC for ICW measurements was 
0.67 which indicates good intra-rater reliability. The ICC for IPMW measurements 
was 0.80 which indicates good intra-rater reliability. The ICC for SI measurements 
was 0.85 which indicates good intra-rater reliability.   
 
 
 
89 
 
 
 
 
N for 5 years, 10 years 
Active PSO 
n= 20, n= 15 
Passive PSO 
n= 20, n= 22 
P value  
5
 y
e
a
rs
 
Mean age (years) 
Range 
Standard Deviation  
5.60 
(4.92-8.83) 
SD 0.92 
6.24 
(4.92-8.33) 
SD 1.04 
0.05 
Angle Classification 
Standard Deviation 
2.15 
SD 0.94 
2.20 
SD 0.89 
0.86 
MHB Classification 
Range 
Standard Deviation  
-7.50 
(-17.0-3.00) 
SD 6.53 
-6.85 
(-19.0-5.00) 
SD 5.78 
0.74 
GOSLON Yardstick 
Standard Deviation  
3.20 
SD 1.37 
3.15 
SD 1.27 
0.73 
1
0
 y
e
a
rs
 
Mean age (years) 
Range 
Standard Deviation 
9.37 
(7.00-12.3) 
SD 1.62 
9.95 
(7.67-11.4) 
SD 0.95 
0.18 
Angle Classification 
Standard Deviation 
2.07 
SD 0.71 
2.05 
SD 0.79 
0.93 
MHB Classification 
Range 
Standard Deviation 
-6.43 
(-22.0-9.00) 
SD 9.85 
-5.41 
(-24.0-5.00) 
SD 7.99 
0.58 
GOSLON Yardstick 
Standard Deviation 
3.00 
SD 1.72 
2.59 
SD 1.22 
0.13 
Table 8: Angle, MHB, and GOSLON Yardstick classification at 5 and 10 years. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N for 5 years, 10 years 
Active PSO 
n= 20, n= 15 
Passive PSO 
n= 20, n= 22 
P value 
 
 
 
90 
 
 
5
 y
e
a
rs
 
Overjet (mm) 
Range 
Standard Deviation 
-0.07 
(-6.50-4.10) 
SD 3.03 
0.12 
(-4.10-4.10) 
SD 2.21 
0.82 
Inter-canine width (mm) 
Range 
Standard Deviation 
25.7 
(18.2-28.3) 
SD 2.36 
25.9 
(19.0-33.1) 
SD 3.92 
0.81 
Inter-palatal molar width (mm) 
Range 
Standard Deviation 
35.0 
(28.2-44.0) 
3.48 
33.8 
(24.1-48.4) 
5.64 
0.45 
Sum of incisors (mm) 
Range 
Standard Deviation 
21.7 
(18.6-28.7) 
SD 2.41 
21.9 
(15.1-27.0) 
SD 3.22 
0.79 
1
0
 y
e
a
rs
 
Overjet (mm) 
Range 
Standard Deviation 
0.77 
(-7.30-5.00) 
SD 3.87 
0.40 
(-5.00-5.00) 
SD 2.96 
0.73 
Inter-canine width (mm) 
Range 
Standard Deviation 
28.5 
(20.9-36.8) 
SD 5.20 
29.8 
(19.7-39.0) 
SD 5.05 
0.41 
Inter-palatal molar width (mm) 
Range 
Standard Deviation 
42.7 
(35.6-47.1) 
SD 3.77 
40.3 
(32.1-50.4) 
SD 3.79 
0.10 
Sum of incisors (mm) 
Range 
Standard Deviation 
24.0 
(18.9-32.2) 
SD 4.43 
26.2 
(19.1-33.0) 
SD 3.88 
0.14 
Table 9: Overjet, inter-canine width, inter-palatal molar width, and sum of incisors 
at 5 and 10 years. 
 
 
Figure 27: Number of patients in each Angle classification group at 5 years. 
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Figure 28: Number of patients in each GOSLON yardstick classification group at 5 
years. 
 
 
Figure 29: Number of patients in each Angle classification group at 10 years. 
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Figure 30: Number of patients in each GOSLON yardstick classification group at 
10 years. 
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Figure 31: Change in occlusion and dental arch relationships from 5 to 10 years. 
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1.3.5 Cephalometric Measurements 
 
For 5-year cephalometric analysis, mean age of measurements was 5.93 years 
(n=18) for patients in the active device group and 6.47 years (n=20) for patients in 
the passive group (p=0.17). For 10-year cephalometric analysis, mean age of 
measurements was 9.62 years (n=16) for patients with an active device and 9.97 
years (n=23) for patients with a passive device (p=0.37).  
 
 
1.3.6 Maxillary Growth Measurements 
 
At 5 years, there was no significant difference between the two groups for the 
length of the maxillary palate (PNS-ANS), depth of the midface (Ba-A), length of 
the maxilla (Ba-ANS), maxillary protrusion (SNA), horizontal distance between 
nasion and A-point (N-A), maxillary position at A-point (Ba-N-A) and the maxillary 
position at ANS (Ba-N-ANS) (p=0.03, p=0.03, p=0.04, p=0.48, p=0.43, p=0.31, 
p=0.39). At 10 years, there was also no difference between the active and passive 
device patients (Table 10). A p-value of less than 0.01 was considered significant 
using the Bonferroni correction.  
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N for 5 years, 10 years 
Active PSO 
n= 18, n= 16 
Passive PSO 
n= 20, n= 23 
P value 
(<0.01) 
5
 y
e
a
rs
 
Mean age (years) 
SNA (o) 
N-A (mm) 
PNS-ANS (mm) 
Ba-A (mm) 
Ba-ANS (mm) 
Ba-N-ANS (o) 
Ba-N-A (o) 
5.93 
77.7 
-3.99 
41.8 
77.2 
80.7 
63.1 
58.5 
6.47 
78.8 
-3.01 
45.1 
82.4 
85.9 
64.6 
60.0 
0.17 
0.48 
0.43 
0.03 
0.03 
0.04 
0.39 
0.31 
1
0
 y
e
a
rs
 
Mean age (years) 
SNA (o) 
N-A (mm) 
PNS-ANS (mm) 
Ba-A (mm) 
Ba-ANS (mm) 
Ba-N-ANS (o) 
Ba-N-A (o)  
9.62 
75.0 
-7.10 
44.6 
79.7 
83.9 
61.5 
56.6 
9.97 
76.1 
-6.10 
43.3 
77.0 
80.9 
61.5 
56.8 
0.37 
0.44 
0.44 
0.51 
0.40 
0.37 
1.00 
0.83 
Table 10: Maxillary growth measurements at 5 and 10 years. With Bonferroni 
correction p-value <0.01 was considered significant. 
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1.3.7 Mandibular Growth Measurements 
 
Mandibular growth measurements were similar between both groups at the 5 and 
10-year mark (Table 11). Mandibular growth measurements included mandibular 
protrusion (SNB), horizontal distance between nasion and B-point (N-B), horizontal 
distance between nasion and pogonion (N-Pg), mandibular position at the 
pogonion (Ba-N-Pg), and mandibular position at B-point (Ba-N-B). A p-value of 
less than 0.01 was considered significant using the Bonferroni correction. 
 
 
 
 
N for 5 years, 10 years 
Active PSO 
n= 18, n= 16 
Passive PSO 
n= 20, n= 23 
P value 
(<0.01) 
5
 y
e
a
rs
 
Mean age (years) 
SNB (o) 
N-B  
N-Pg  
Ba-N-Pg (o) 
Ba-N-B (o) 
5.93 
74.0 
-11.9 
-13.0 
55.1 
54.8 
6.47 
75.1 
-10.3 
-11.1 
56.6 
56.3 
0.17 
0.42 
0.40 
0.36 
0.14 
0.18 
1
0
 y
e
a
rs
 
Mean age (years) 
SNB (o) 
N-B  
N-Pg  
Ba-N-Pg (o) 
Ba-N-B (o) 
9.62 
74.1 
-13.2 
-13.8 
56.4 
55.6  
9.97 
74.5 
-12.4 
-12.5 
56.2 
55.3 
0.37 
0.74 
0.72 
0.60 
0.88 
0.83 
Table 11: Mandibular growth at 5 and 10 years. With Bonferroni correction p-
value <0.01 was considered significant. 
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1.3.8 Dento-alveolar Relationships 
 
Dento-alveolar measurements were similar between groups at 5 and 10 years. 
Dentoalveolar measurements included position of maxilla relative to mandible 
(ANB), alveolus to basal bone measurement (ANS-N-A), and basal bone 
difference (ANS-N-Pg). There were no differences between the two groups at 5 
and 10 years (Table 12). A p-value of less than 0.02 was considered significant 
using the Bonferroni correction. 
 
 
 
 
N for 5 years, 10 years 
Active PSO 
n= 18, n= 16 
Passive PSO 
n= 20, n= 23 
P value 
(<0.02) 
5
 y
e
a
rs
 Mean age (years) 
ANB (o) 
ANS-N-A (o) 
ANS-N-Pg (o) 
5.93 
3.68 
4.66 
165.3  
6.47 
3.69 
4.59 
165.5 
0.84 
1.00 
0.91 
0.93  
1
0
 y
e
a
rs
 Mean age (years) 
ANB (o) 
ANS-N-A (o) 
ANS-N-Pg (o) 
9.62 
0.99 
4.98 
147.9 
9.97 
1.58 
4.66 
154.4 
0.37 
0.57 
0.50 
0.80 
Table 12: Dento-alveolar growth measurements at 5 and 10 years. With 
Bonferroni correction p-value <0.02 was considered significant. 
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1.3.9 Vertical Facial Growth 
 
At 5 and 10 years there was no significant difference between the groups for any 
vertical facial growth factors (Table 13). Vertical facial growth factors included 
upper facial height (N-ANS), lower facial height (ANS-Me), upper to lower facial 
height ratio (N-ANS/ANS-Me), and midface percent of total facial height (N-ANS/N-
Me) were not significantly different between the two groups. A p-value of less than 
0.01 was considered significant using the Bonferroni correction. 
 
 
 
 
N for 5 years, 10 years 
Active PSO 
n= 18, n= 13 
Passive PSO 
n= 20, n= 23 
P value 
(<0.01) 
5
 y
e
a
rs
 
Mean age (years) 
N-ANS (ratio) 
ANS-Me (ratio) 
N-ANS/ANS-Me (ratio) 
N-ANS/N-Me (ratio) 
5.93 
39.0 
58.2 
0.74 
0.43 
6.47 
43.0 
56.9 
0.76 
0.44 
0.17 
0.01 
0.03 
0.35 
0.42 
1
0
 y
e
a
rs
 
Mean age (years) 
N-ANS (ratio) 
ANS-Me (ratio) 
N-ANS/ANS-Me (ratio) 
N-ANS/N-Me (ratio) 
9.62 
44.3 
57.4 
0.77 
0.44 
9.97 
44.3 
56.3 
0.79 
0.44 
0.37 
0.98 
0.65 
0.46 
0.49 
Table 13: Vertical facial growth measurements at 5 and 10 years. With 
Bonferroni correction p-value <0.01 was considered significant. 
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1.3.10 Soft Tissue Growth 
 
Soft tissue growth measurements included soft tissue convexity, soft tissue profile, 
facial contour angle, and nasolabial angle (Table 14). There was no significant 
difference between groups at 5 and 10 years. A p-value of less than 0.02 was 
considered significant using the Bonferroni correction. 
 
 
  
N for 5 years, 10 years 
Active PSO 
n= 18, n= 13 
Passive PSO 
n= 20, n= 23 
P value 
(<0.02) 
5
 y
e
a
rs
 Mean age (years) 
Soft tissue convexity (o) 
Facial contour angle (o) 
Nasolabial angle (o)  
5.93 
141.9 
-5.54 
110.7  
6.47 
140.0 
-6.36 
113.1  
0.17 
0.34 
0.63 
0.45  
1
0
 y
e
a
rs
 Mean age (years) 
Soft tissue convexity (o) 
Facial contour angle (o) 
Nasolabial angle (o) 
9.62 
143.7 
-1.41 
99.8 
9.97 
140.8 
-5.11 
106.8  
0.37 
0.12 
0.06 
0.02 
Table 14: Soft tissue growth at 5 and 10 years. With Bonferroni correction p-
value <0.02 was considered significant. 
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1.3.11 Growth Between Five and Ten Years 
 
A comparison of growth between the 5-year and 10-year measurements was also 
performed (Table 15). A total of 16 patients in the active device group and 18 
patients in the passive device group had records for this comparison. Growth in 
the maxilla, mandible, dento-alveolar relationships, vertical facial height, and soft 
tissue values was not significantly different between the 2 groups. 
 
 
1.3.12 Intra-rater Reliability 
 
Intra-class correlation coefficient was calculated for cephalometric measurements. 
The ICC value was 0.81 which represents good intra-rater reliability.  
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N for 5 years, 10 years 
Active PSO 
n= 16 
Passive PSO 
n= 18 
P value 
M
a
x
ill
a
 
SNA 
N-A 
PNS-ANS 
Ba-A 
Ba-ANS 
Ba-N-ANS 
Ba-N-A  
-2.64 
-3.08 
2.53 
2.01 
2.63 
-1.51 
-1.81 
-2.93 
-3.23 
-2.58 
-7.06 
-6.69 
-3.41 
-3.43 
0.80 
0.89 
0.06 
0.02 
0.03 
0.21 
0.26  
M
a
n
d
ib
le
 SNB 
N-B 
Pg-N 
Ba-N-Pg 
Ba-N-B 
0.33 
-0.89 
-0.28 
1.74 
1.17 
-0.36 
-1.45 
-0.63 
-0.21 
-0.83 
0.40 
0.64 
0.82 
0.04 
0.04 
D
e
n
to
-
a
lv
e
o
la
r 
 
ANB 
A-N-ANS 
N-ANS-Pg 
-2.96 
0.31 
-16.8 
-2.61 
0.04 
-14.5 
0.70 
0.73 
0.94 
V
e
rt
ic
a
l 
F
a
c
e
  
N-ANS 
ANS-Me 
N-ANS/ANS-Me 
N-ANS/N-Me 
5.14 
3.88 
0.04 
0.01 
0.77 
-2.47 
0.45 
0.11 
0.08 
0.03 
0.79 
0.78 
S
o
ft
 
T
is
s
u
e
  Soft tissue convexity 
Facial contour angle 
Nasolabial angle 
1.39 
4.49 
-11.7 
0.70 
1.32 
-6.93 
0.70 
0.02 
0.18 
Table 15: Facial growth between 5 and 10 years. Significant p-values were 
considered <0.01 for maxilla growth, mandible growth, and vertical facial growth 
and <0.02 for dento-alveolar growth and soft tissue growth. 
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 DISCUSSION  
 
In the present study, patients being treated with a passive PSO device had 
significantly larger horizontal alveolar gaps at the time of lip repair. This 
discrepancy indicates that the passive device is not as effective at narrowing the 
alveolar gap compared to the active device. The patients treated with an active 
PSO device had larger cleft-side alar base measurements compared to the 
passive device patients at the time of lip repair. This could be explained by the fact 
that the passive device employs a nasal stent which also serves to mold the alar 
base, while patients with an active device had an intra-oral device that provides no 
nasal molding. By the time of palate repair patients in both device groups had 
similar measurements for alar base, palate width, and alveolar gap width. Patients 
in the active and passive device groups had similar rates of face mask application, 
braces application, lip revision, bone grafting, and VPI, all of which suggests that 
the patient group did not influence the number of additional procedures required 
following palate repair. In summary, patients in the active and passive device 
groups had comparable severity of their alveolar gap by the time of palate repair 
and similar management protocols. This is the first study comparing dental 
occlusion and facial growth where patients were matched for cleft severity and 
management protocol.  
 
 
1.4.1 Dental Arch and Occlusion 
 
The present study is the largest long-term study comparing dental arch 
relationships in patients treated with an active versus a passive PSO device. 
Overall, this study showed no difference in dental arch relationships between 
patients treated with an active or a passive device. All groups had an Angle 
classification grade that indicated a degree of overjet/overbite, a negative MHB 
score  indicative of a degree of maxillary arch growth restriction (141), and a 
GOSLON yardstick score  that indicates positive/minimal overjet and predicts good 
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outcomes following orthognathic surgery. When comparing changes from 5 to 10 
years within patients, there were no differences between the groups. Angle 
classification, MHB score, GOSLON score, and overjet improved in both patient 
groups from 5 to 10 years although the changes did not reach significance. 
Improved occlusal scores from 5 to 10 years could be secondary to the use of 
braces and targeted dental extraction to allow for teeth to fit in anatomic alignment.  
 
Assessing the width of the dental arch is important for determining whether 
patients have deficient palatal growth/expansion. While it has been shown that 
palatal surgery does cause some dental arch restriction, the effect of PSO devices 
on dental arch growth is unknown (142).  To our knowledge, this is the first study 
to make the comparison in patients treated with active versus passive devices. 
When comparing the development of the dental arch in patients treated with a PSO 
device, there have been a handful of studies that have shown decreased maxillary 
arch collapse in patients treated with a passive device compared to no device 
(54,123,124). Unfortunately, these studies showing improved arch collapse only 
examined patients up to 18 months of age and so they cannot be used to 
extrapolate how the arch behaves as the patient grows older. A previous study by 
Banker et al. has reported that an IPMW to ICW ratio of 1:1 +/- 0.5 is indicative of 
normal arch development and a ratio of greater than 1.15:1 indicates deficient arch 
development (143). This ratio was 1.50 in patients with an active device and 1.35 
in patients with a palate device, which indicates both patient groups had a degree 
of dental arch deficiency. This same study by Banker et al. also used an IPMW of 
under 34.92mm as an indicator for arch restriction. Using this criterion our patients 
would not be considered to have a restricted arch; at 10 years patients with an 
active device had an IPMW of 42.7mm and patients with a passive device had an 
IPMW of 40.3mm. Furthermore, both groups showed an overall expansion of the 
IPMW and the ICW from 5 to 10 years which is consistent with no restriction of the 
maxillary dental arch. 
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In summary, patients treated with an active device had comparable dental 
occlusion and dental arch width compared to patients treated with a passive 
device. The reported dental arch measurements indicate that there may be a small 
degree of maxillary arch restriction in both groups, although both groups still had 
growth in the arch from 5 to 10 years. 
 
 
1.4.2 Facial Growth 
 
Overall, this study found comparable facial growth outcomes between patients 
treated with an active versus a passive PSO device at 5 and 10 years. Before 
Bonferroni correction anterior/posterior and vertical maxillary growth was 
significantly smaller in patients treated with an active device at 5 years. Loss of 
significance following Bonferroni correction indicates that these differences can be 
explained by chance from repeated measurements and not by the effects of the 
device itself. The similarity in dentoalveolar relationships measured via 
cephalometric analysis reinforces the validity of the similar occlusal relationships 
that were found using the patient molds. Regarding the changes in growth from 5 
to 10 years, patients had similar growth of the maxilla, mandible, dento-alveolar 
relationships, vertical facial height, and soft tissue values.  
 
Previous research has shown that PSO devices, specifically active devices, cause 
a maxillary growth restriction (35,44). To our knowledge, there are few studies that 
have reported negative maxillary growth outcomes with the use of a passive 
device. The results from this study indicate that active devices do not restrict 
maxillary growth compared to passive devices. Furthermore, the reported average 
measurements for SNA angle (maxillary length) and SNB angle (mandibular 
length) in this study are similar to previously reported outcomes for patients with 
CL/P treated without a PSO device. Those studies reported an average SNA angle 
of 76.4 to 80.5 compared to our reported 75.0 to 78.9 and an SNB of 74.4 to 75.4 
compared to our reported 74.0 to 75.1(144,145). While these groups cannot be 
 
 
 
105 
 
 
compared statistically because they are from different studies, this finding further 
supports our conclusion that the active and passive devices do not appear to 
negatively affect maxillary growth. 
 
In summary, patients treated with an active device have similar facial growth to 
patients treated with a passive device up 10 years of age.  
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 CONCLUSION 
 
Overall, the results of this study indicate that dental occlusion/dental arch 
development and facial growth are similar between patients treated with an active 
or a passive PSO device. Patients treated with either device have a degree of 
overbite/overjet at the level of the molars (Angle 2) with good expected outcomes 
following orthognathic surgery (GOSLON 3). Neither device causes a significant 
amount of dental arch restriction. Overall, at 10 years patients in the active and 
passive device groups also have comparable facial growth. Moving forward, a 
prospective study that compares the use of passive and active PSO devices to 
patients with no device (with matched cleft severity) would elucidate whether 
patients with these devices develop occlusion and facial growth different to 
patients treated without a PSO device.  
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Chapter 5: General Discussion and Conclusion  
 
This chapter will briefly outline the hypothesis and objectives of this thesis. This 
chapter will summarize the results of Chapter 2 through 4 and discuss weaknesses 
and strengths of each study. Finally, future directions of this study will be 
discussed.  
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 SUMMARY 
 
The purpose of this work was to review the current literature pertaining to long-
term outcomes associated with pre-surgical orthopedic (PSO) devices used in the 
management of cleft lip and palate and to study the long-term effects of these 
devices.  
 
The objectives of this thesis were to: 
 
1. Perform a systematic review of current literature describing the long-term 
effects of different PSO devices used in the management of cleft palate. 
(CHAPTER 0) 
2. To evaluate and compare 1-year, 5-year, and 10-year nasolabial aesthetic 
changes in patients who received treatment with an active PSO device, 
passive PSO device, or no PSO device. (CHAPTER 0) 
3. To evaluate and compare 5-year and 10-year dental occlusion/dental arch 
development in patients who had treatment with an active PSO or passive 
PSO device. (CHAPTER 0) 
4. To evaluate and compare 5-year and 10-year facial growth in patients who 
had treatment with an active PSO device or passive PSO device at 5 years 
and 10 years in order to determine whether there is a difference in facial 
development between these groups. (CHAPTER 0) 
 
The findings of Chapters 2, 3, and 4 are reviewed below. 
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 SUMMARY OF CHAPTER 2: SYSTEMATIC REVIEW OF THE LITERATURE ON 
THE LONG-TERM PATIENT OUTCOMES ASSOCIATED WITH PRE-SURGICAL 
ORTHOPEDIC DEVICES 
 
The primary objective of this chapter was to perform a systematic review of the 
literature pertaining to long-term outcomes in patients who were treated with PSO 
devices. The search criteria were developed with assistance from a librarian and 
the results of the search were reviewed by 2 independent reviewers using strict 
inclusion and exclusion criteria. The reference lists of the included studies were 
also screened for inclusion.  
 
The literature review produced a total of 41 articles for inclusion. These studies 
highlighted the existence of multiple confounding factors that often occur between 
comparison groups. These factors make it difficult to determine whether the 
reported outcomes are due to the devices or the confounding factors, and 
ultimately limit the applicability of the study results. Described confounding factors 
include the severity of the initial alveolar gap, different operating surgeons, and 
different management protocols. Secondly, the review highlighted that there is no 
consensus in the literature as to the long-term effects of PSO devices on patient 
outcomes. Thirdly, this systematic review highlighted the lack of studies comparing 
long-term patient outcomes between patients that are treated with active versus 
passive PSO devices. In summary, the results from this systematic review 
confirmed the initial study hypothesis that there is no consensus in the literature 
regarding the effects of these devices and that the literature that does exist is 
weakened by the heterogeneity that exists in between and within the different 
comparison groups.  
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 SUMMARY OF CHAPTER 3: 10-YEAR NASOLABIAL AESTHETIC 
COMPARISON IN PATIENTS WITH DIFFERENT PRE-SURGICAL 
ORTHOPEDIC DEVICES  
 
The primary objective of this chapter was to assess the 10-year nasolabial 
aesthetic outcomes of patients treated with an active PSO device, passive PSO 
device, or no device. Patients were included if they had a unilateral complete or 
incomplete primary cleft palate and were operated on by the principle surgeon. 
Nasolabial aesthetics were assessed using 2-dimensional facial photographs for 
patients taken at 3 time points (1 year, 5 years, 10 years). A total of 11 nasolabial 
variables were assessed for each photograph.  
 
There were two principle findings in this study. The first finding was that patients 
treated with PSO devices had larger alveolar gaps compared to patients treated 
without a PSO device. Despite having worse alveolar gaps, patients treated with 
either PSO device had comparable 10-year nasolabial aesthetic outcomes to 
patients with less severe gaps that did not require device treatment. The second 
finding of this study was that despite passive devices providing a nasal molding 
component, there was no difference in nasal outcomes between patients treated 
with an active or a passive PSO device. Overall, PSO device treatment helps 
patients with more severe alveolar gaps achieve nasolabial aesthetic results 
similar to patients with less severe gaps. 
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 SUMMARY OF CHAPTER 4: 10-YEAR DENTAL OCCLUSION AND FACIAL 
GROWTH COMPARISON IN PATIENTS WITH DIFFERENT PRE-SURGICAL 
ORTHOPEDIC DEVICES 
 
The primary objective of this chapter was to compare the 10-year dental occlusion 
and facial growth outcomes in patients treated with an active PSO device versus 
a passive PSO device over a 10-year period. Dental occlusion was assessed by 
evaluating patients’ dental models at 5 and 10 years. Facial growth was assessed 
through cephalometric analysis of lateral patient radiographs at the same time 
points.  
 
There were 3 principle results found in this study. Firstly, patients treated with 
active or passive PSO devices had similar dental occlusion and dental arch 
development over a 10-year period. Secondly, neither PSO device cause a 
restriction in the growth of the maxillary arch. Thirdly, patients treated with an 
active PSO device had similar facial growth to patients treated with a passive 
device.  
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 STRENGTHS AND LIMITATIONS 
 
There are multiple strengths and weaknesses associated with this work. The 
strength of Chapter 2 lies in the fact that it provides a thorough summary of the 
current state of knowledge in this field. This systematic review was an exhaustive 
search of all literature pertaining to this subject. A meta-analysis would be a more 
powerful summary of results, but unfortunately the described results were too 
heterogenous for this type of analysis.  
 
Chapters 3 and 4 share some similar strengths and weaknesses. In terms of 
weaknesses, both studies are retrospective. Retrospective studies may be 
influenced by selection bias. Strengths of these studies include that all groups were 
operated on by the same surgeon and had the same management protocol. These 
similarities help eliminate many confounding factors that could influence study 
results. Thirdly, these are 2 of the largest studies comparing these 3 groups over 
a 10-year period which makes this a very valuable study for understanding long-
term patient outcomes. Finally, the 10-year follow-up period is another strength of 
the aforementioned studies. Frequently, cleft palate research is limited to follow-
up at 1 to 5 years. A significant proportion of growth and development occurs 
between 5 and 10 years of age; an important factor to acknowledge when studying 
these populations. The 10-year follow-up period in this work accounts for important 
facial changes that can influence patient outcomes. Conversely, the follow-up 
period is also a weakness; patients still grow up to 18 to 20 years so growth 
changes following the 10-year follow-up period are not addressed. 
 
Specific to Chapter 3, a limitation of this study was that patients in the PSO and no 
PSO device groups were not matched for alveolar gap severity; patients treated 
with no device had small complete or incomplete alveolar gaps and were often not 
treated with palate surgery. Palate surgery is a variable that is known to affect 
maxillary growth, which by extension could affect nasolabial aesthetics by 
changing lip protrusion. Patients in the no device group also had significantly less 
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severe alveolar gaps compared to patients treated with PSO devices. These 
differences are potential confounding factors and therefore, the patients treated 
with PSO devices versus no device cannot be directly compared in order to 
determine if using a PSO device is superior to not using a device. Despite this, it 
is still possible to judge whether the PSO devices make nasolabial aesthetics 
similar to nasolabial aesthetics in patients treated without a device who start with 
more severe alveolar gaps. Secondly, patients did differ in their rates of lip revision, 
but this was accounted for through analysis of patients excluding those who 
received lip revision surgery.  
 
Specific to Chapter 4, the main limitation is also that it is a retrospective study. 
Therefore, some selection bias may exist between the two groups. A strength of 
this study was that the 2 comparison groups in this chapter were matched for 
alveolar gap severity. Very few studies in cleft palate research have groups 
matched for alveolar gap severity, which is a factor that could confound results. 
Secondly, to our knowledge this is the largest study comparing outcomes between 
patients treated with an active or passive PSO device with all possible surgical 
confounding factors eliminated.  
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 FUTURE DIRECTIONS 
 
Chapter 2 highlighted the necessity for a single-surgeon study examining the long-
term nasolabial aesthetic, dental occlusion, and facial growth outcomes in patients 
treated with both active and passive PSO devices. In addition, this chapter also 
highlighted the need for studies actually comparing the different types of PSO 
devices. This is exactly what was performed in Chapters 3 and 4. In regard to 
future directions for this study, this study will be repeated in the next 3 to 4 years 
to examine 15-year outcomes in these patient groups. There are few 15-year 
follow-up studies in cleft palate literature, and currently no studies comparing 
active and passive PSO device patients who are matched for cleft severity. 
Unfortunately, the majority of the study patients are too young for 15-year follow-
up analysis at this time, but this will be repeated when all of these study patients 
have reached 15 years old.  
 
A question that this work does not answer is whether PSO devices are truly 
required to have adequate growth and aesthetic outcomes. To answer this 
question, patients treated with no device with alveolar gaps of equal severity would 
also need to be compared. A population like this does not currently exist in our 
patient cohort. A second future direction for this research could be a prospective 
study that directly compares nasolabial aesthetics, dental occlusion, and facial 
growth in patients treated with an active, passive, or no PSO device. A prospective 
study of this nature with groups that are matched for the severity of their alveolar 
gap would be an important way of assessing whether PSO devices are truly 
required to have improved facial growth and dental occlusion.      
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 SIGNIFICANCE  
 
The use of PSO devices for patients with cleft palate is still a highly debated topic. 
Surgeons base their decision to use a certain PSO device on experience, surgeon 
preference, and family preference. A lot of limitations exist in research on this 
subject, and Chapter 2 highlights a number of the limitations that exist in this area 
of research. This is the first systematic review to highlight these limitations in a 
quantitative manner. The significance of this systematic review is that it has 
highlighted the need for research with more strict methodology. This systematic 
review can be used to guide future research in this field.  
 
Chapters 3 and 4 outlined the long-term effects of using passive and active PSO 
devices in patients with cleft lip/palate. These two studies are the first single-
surgeon studies to examine the impact of both active and passive devices on 
nasolabial aesthetics, dental occlusion, and facial growth. In addition, these are 
the first single-surgeon studies to control for cleft severity and surgical 
management between the different patient groups. Overall, this is the largest study 
examining the long-term effects of PSO devices between patients treated with an 
active or a passive device where confounding factors including the operating 
surgeon, surgical management, and cleft severity are all controlled.  
 
There is concern in the cleft palate community about how PSO devices affect 
maxillary growth, dental occlusion, and nasolabial aesthetics. Specifically, a large 
amount of concern lies in whether active devices reduce maxillary growth. The 
results from Chapter 4 allow us to conclude that overall, patients treated with an 
active device have comparable growth to patients treated with a passive device. 
These results may encourage surgeons who were hesitant to use active devices 
for this reason.  Secondly, passive devices are often used in patients with cleft 
lip/palate for the nasal molding component. This work showed that passive devices 
do not produce superior nasal aesthetics compared to active PSO devices. Thirdly, 
this work showed that using a PSO device in larger clefts can help achieve 
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nasolabial aesthetic outcomes similar to patients with less severe clefts. Overall, 
the results of this work have disproven several current theories about PSO 
devices. This work can help guide cleft surgeons with their PSO device selection 
and may encourage the use of different PSO devices for different patients.   
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Appendices 
 
 APPENDIX 1- GLOSSARY 
 
NAM device: passive PSO device 
Latham device: active PSO device  
Sella turcica (S): center of the sella turcica  
Nasion (N): most superior point of the frontonasal suture  
A point (A): most posterior point on the curve between the ANS and the PR 
Anterior nasal spine (ANS): most anterior point on the maxilla at the level of the 
palate  
Posterior nasal spine (PNS): most posterior point on the boney hard palate  
Basion (Ba): most inferior posterior point on anterior rim of foramen magnum 
(tip of posterior cranial base) 
B point (B): most posterior point of bony curvature of the mandible 
Pogonion (Pg): most anterior point on mandibular symphysis 
Menton (Me): lowest point on chin 
Soft tissue nasion (N’): soft tissue marker of most superior point of the 
frontonasal suture 
Soft tissue A-point (A’): soft tissue marker of most posterior point on the curve 
between the ANS and the PR 
Soft tissue pogonion (Pg’): most anterior point on chin 
Soft tissue gnathion (G’): most anterior inferior point  
Pronasale (Pn): most anterior tip of nose 
Columella (Col): midpoint on the lower surface of the nose 
Subnasale (Sn): junction of where the base of the columella meets the upper 
lip 
 
 
 
 APPENDIX 2- NASOLABIAL AESTHETIC RATING SCALE 
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